
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Identification of Novel BRCA1 and RAD50 Mutations Associated With Breast Cancer Predisposition in Tunisian Patients - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="DB2B3B359264E5D33C3B35001FBFE21E.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="frontgene">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7677579/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Frontiers in Genetics">
<meta name="citation_title" content="Identification of Novel BRCA1 and RAD50 Mutations Associated With Breast Cancer Predisposition in Tunisian Patients">
<meta name="citation_author" content="Najah Mighri">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author" content="Yosr Hamdi">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author" content="Maroua Boujemaa">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author" content="Houcemeddine Othman">
<meta name="citation_author_institution" content="Sydney Brenner Institute for Molecular Bioscience, University of the Witwatersrand, Johannesburg, South Africa">
<meta name="citation_author" content="Sonia Ben Nasr">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author_institution" content="The Military Hospital of Tunis, Department of Medical Oncology, Tunis, Tunisia">
<meta name="citation_author" content="Houda El Benna">
<meta name="citation_author_institution" content="Department of Medical Oncology, Abderrahmane Mami Hospital, Ariana, Tunisia">
<meta name="citation_author" content="Nesrine Mejri">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author_institution" content="Department of Medical Oncology, Abderrahmane Mami Hospital, Ariana, Tunisia">
<meta name="citation_author" content="Soumaya Labidi">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author_institution" content="Department of Medical Oncology, Abderrahmane Mami Hospital, Ariana, Tunisia">
<meta name="citation_author" content="Jihen Ayari">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author_institution" content="The Military Hospital of Tunis, Department of Medical Oncology, Tunis, Tunisia">
<meta name="citation_author" content="Olfa Jaidene">
<meta name="citation_author_institution" content="Department of Carcinological Surgery, Salah Azaiez Institute, Tunis, Tunisia">
<meta name="citation_author" content="Hanen Bouaziz">
<meta name="citation_author_institution" content="Department of Carcinological Surgery, Salah Azaiez Institute, Tunis, Tunisia">
<meta name="citation_author" content="Mariem Ben Rekaya">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author" content="Ridha M’rad">
<meta name="citation_author_institution" content="Service des Maladies Congénitales et Héréditaires, Hôpital Charles Nicolle, Tunis, Tunisia">
<meta name="citation_author" content="Abderrazek Haddaoui">
<meta name="citation_author_institution" content="The Military Hospital of Tunis, Department of Medical Oncology, Tunis, Tunisia">
<meta name="citation_author" content="Khaled Rahal">
<meta name="citation_author_institution" content="Department of Carcinological Surgery, Salah Azaiez Institute, Tunis, Tunisia">
<meta name="citation_author" content="Hamouda Boussen">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author_institution" content="Department of Medical Oncology, Abderrahmane Mami Hospital, Ariana, Tunisia">
<meta name="citation_author" content="Samir Boubaker">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author" content="Sonia Abdelhak">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_publication_date" content="2020 Nov 6">
<meta name="citation_volume" content="11">
<meta name="citation_firstpage" content="552971">
<meta name="citation_doi" content="10.3389/fgene.2020.552971">
<meta name="citation_pmid" content="33240314">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7677579/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7677579/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7677579/pdf/fgene-11-552971.pdf">
<meta name="description" content="Deleterious mutations on BRCA1/2 genes are known to confer high risk of developing breast and ovarian cancers. The identification of these mutations not only helped in selecting high risk individuals that need appropriate prevention approaches but ...">
<meta name="og:title" content="Identification of Novel BRCA1 and RAD50 Mutations Associated With Breast Cancer Predisposition in Tunisian Patients">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Deleterious mutations on BRCA1/2 genes are known to confer high risk of developing breast and ovarian cancers. The identification of these mutations not only helped in selecting high risk individuals that need appropriate prevention approaches but ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7677579/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="7677579">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3389/fgene.2020.552971"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/fgene-11-552971.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC7677579%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/7677579/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/7677579/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC7677579/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-frontgene.gif" alt="Frontiers in Genetics logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Frontiers in Genetics" title="Link to Frontiers in Genetics" shape="default" href="http://www.frontiersin.org/genetics" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Front Genet</button></div>. 2020 Nov 6;11:552971. doi: <a href="https://doi.org/10.3389/fgene.2020.552971" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3389/fgene.2020.552971</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Front%20Genet%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Front%20Genet%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Front%20Genet%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Front%20Genet%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Identification of Novel <em>BRCA1</em> and <em>RAD50</em> Mutations Associated With Breast Cancer Predisposition in Tunisian Patients</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mighri%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Najah Mighri</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Najah Mighri</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mighri%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Najah Mighri</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hamdi%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Yosr Hamdi</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Yosr Hamdi</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hamdi%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yosr Hamdi</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boujemaa%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Maroua Boujemaa</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Maroua Boujemaa</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boujemaa%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Maroua Boujemaa</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Othman%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Houcemeddine Othman</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Houcemeddine Othman</span></h3>
<div class="p">
<sup>2</sup>Sydney Brenner Institute for Molecular Bioscience, University of the Witwatersrand, Johannesburg, South Africa</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Othman%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Houcemeddine Othman</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ben%20Nasr%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Sonia Ben Nasr</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Sonia Ben Nasr</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">
<sup>3</sup>The Military Hospital of Tunis, Department of Medical Oncology, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ben%20Nasr%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sonia Ben Nasr</span></a>
</div>
</div>
<sup>1,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22El%20Benna%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Houda El Benna</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Houda El Benna</span></h3>
<div class="p">
<sup>4</sup>Department of Medical Oncology, Abderrahmane Mami Hospital, Ariana, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22El%20Benna%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Houda El Benna</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mejri%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Nesrine Mejri</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Nesrine Mejri</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">
<sup>4</sup>Department of Medical Oncology, Abderrahmane Mami Hospital, Ariana, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mejri%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nesrine Mejri</span></a>
</div>
</div>
<sup>1,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Labidi%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Soumaya Labidi</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Soumaya Labidi</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">
<sup>4</sup>Department of Medical Oncology, Abderrahmane Mami Hospital, Ariana, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Labidi%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Soumaya Labidi</span></a>
</div>
</div>
<sup>1,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ayari%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Jihen Ayari</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Jihen Ayari</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">
<sup>3</sup>The Military Hospital of Tunis, Department of Medical Oncology, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ayari%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jihen Ayari</span></a>
</div>
</div>
<sup>1,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jaidene%20O%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Olfa Jaidene</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Olfa Jaidene</span></h3>
<div class="p">
<sup>5</sup>Department of Carcinological Surgery, Salah Azaiez Institute, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jaidene%20O%22%5BAuthor%5D" class="usa-link"><span class="name western">Olfa Jaidene</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bouaziz%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Hanen Bouaziz</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Hanen Bouaziz</span></h3>
<div class="p">
<sup>5</sup>Department of Carcinological Surgery, Salah Azaiez Institute, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bouaziz%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hanen Bouaziz</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ben%20Rekaya%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Mariem Ben Rekaya</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Mariem Ben Rekaya</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ben%20Rekaya%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mariem Ben Rekaya</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22M%E2%80%99rad%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Ridha M’rad</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Ridha M’rad</span></h3>
<div class="p">
<sup>6</sup>Service des Maladies Congénitales et Héréditaires, Hôpital Charles Nicolle, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22M%E2%80%99rad%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Ridha M’rad</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Haddaoui%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Abderrazek Haddaoui</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Abderrazek Haddaoui</span></h3>
<div class="p">
<sup>3</sup>The Military Hospital of Tunis, Department of Medical Oncology, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Haddaoui%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Abderrazek Haddaoui</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rahal%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Khaled Rahal</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Khaled Rahal</span></h3>
<div class="p">
<sup>5</sup>Department of Carcinological Surgery, Salah Azaiez Institute, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rahal%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Khaled Rahal</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boussen%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Hamouda Boussen</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Hamouda Boussen</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">
<sup>4</sup>Department of Medical Oncology, Abderrahmane Mami Hospital, Ariana, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boussen%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hamouda Boussen</span></a>
</div>
</div>
<sup>1,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boubaker%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Samir Boubaker</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Samir Boubaker</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boubaker%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Samir Boubaker</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Abdelhak%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Sonia Abdelhak</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Sonia Abdelhak</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Abdelhak%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sonia Abdelhak</span></a>
</div>
</div>
<sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div id="aff2">
<sup>2</sup>Sydney Brenner Institute for Molecular Bioscience, University of the Witwatersrand, Johannesburg, South Africa</div>
<div id="aff3">
<sup>3</sup>The Military Hospital of Tunis, Department of Medical Oncology, Tunis, Tunisia</div>
<div id="aff4">
<sup>4</sup>Department of Medical Oncology, Abderrahmane Mami Hospital, Ariana, Tunisia</div>
<div id="aff5">
<sup>5</sup>Department of Carcinological Surgery, Salah Azaiez Institute, Tunis, Tunisia</div>
<div id="aff6">
<sup>6</sup>Service des Maladies Congénitales et Héréditaires, Hôpital Charles Nicolle, Tunis, Tunisia</div>
<div class="author-notes p">
<div class="fn" id="fn1"><p>Edited by: Anna Murray, University of Exeter, United Kingdom</p></div>
<div class="fn" id="fn2"><p>Reviewed by: Natasa Djordjevic, University of Kragujevac, Serbia; Jaakko Tapio Leinonen, University of Helsinki, Finland</p></div>
<div class="fn" id="c001">
<sup>✉</sup><p class="display-inline">*Correspondence: Yosr Hamdi, <span>yosr.hamdi@pasteur.tn</span></p>
</div>
<div class="fn" id="fn004"><p>This article was submitted to Genomic Medicine, a section of the journal Frontiers in Genetics</p></div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2020 Apr 17; Accepted 2020 Oct 16; Collection date 2020.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2020 Mighri, Hamdi, Boujemaa, Othman, Ben Nasr, El Benna, Mejri, Labidi, Ayari, Jaidene, Bouaziz, Ben Rekaya, M’rad, Haddaoui, Rahal, Boussen, Boubaker and Abdelhak.</div>
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC7677579  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33240314/" class="usa-link">33240314</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p>Deleterious mutations on <em>BRCA1/2</em> genes are known to confer high risk of developing breast and ovarian cancers. The identification of these mutations not only helped in selecting high risk individuals that need appropriate prevention approaches but also led to the development of the PARP-inhibitors targeted therapy. This study aims to assess the prevalence of the most frequent <em>BRCA1</em> mutation in Tunisia, c.211dupA, and provide evidence of its common origin as well as its clinicopathological characteristics. We also aimed to identify additional actionable variants using classical and next generation sequencing technologies (NGS) which would allow to implement cost-effective genetic testing in limited resource countries.</p></section><section id="sec2"><h3 class="pmc_sec_title">Patients and Methods</h3>
<p>Using sanger sequencing, 112 breast cancer families were screened for c.211dupA. A set of patients that do not carry this mutation were investigated using NGS. Haplotype analysis was performed to assess the founder effect and to estimate the age of this mutation. Correlations between genetic and clinical data were also performed.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p>The c.211dupA mutation was identified in 8 carriers and a novel private <em>BRCA1</em> mutation, c.2418dupA, was identified in one carrier. Both mutations are likely specific to North-Eastern Tunisia. Haplotype analysis supported the founder effect of c.211dupA and showed its recent origin. Phenotype-genotype correlation showed that both <em>BRCA1</em> mutations seem to be associated with a severe phenotype. Whole Exome Sequencing (WES) analysis of a <em>BRCA</em> negative family revealed a Variant of Unknown Significance, c.3647C &gt; G on <em>RAD50</em>. Molecular modeling showed that this variant could be classified as deleterious as it is responsible for destabilizing the RAD50 protein structure. Variant prioritization and pathway analysis of the WES data showed additional interesting candidate genes including <em>MITF</em> and <em>ANKS6.</em></p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusion</h3>
<p>We recommend the prioritization of <em>BRCA1</em>-c.211dupA screening in high risk breast cancer families originating from the North-East of Tunisia. We also highlighted the importance of NGS in detecting novel mutations, such as <em>RAD50-</em>c.3647C &gt; G. In addition, we strongly recommend using data from different ethnic groups to review the pathogenicity of this variant and reconsider its classification in ClinVar.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> breast cancer, genetic screening, <em>BRCA1</em>-founder mutation, next-generation sequencing, novel mutation, <em>RAD50</em></p></section></section><section id="S1"><h2 class="pmc_sec_title">Introduction</h2>
<p>Breast cancer remains the most common cancer among women worldwide (<a href="#B11" class="usa-link" aria-describedby="B11">Bray et al., 2018</a>). Each year, 2000 new breast cancer cases are diagnosed in Tunisia (<a href="#B11" class="usa-link" aria-describedby="B11">Bray et al., 2018</a>) and the mean age at diagnosis is around 50 years old, a decade younger than Western countries (<a href="#B15" class="usa-link" aria-describedby="B15">Chalabi et al., 2008</a>).</p>
<p><em>BRCA1</em> and <em>BRCA2</em> are the most studied breast cancer susceptibility genes that explain a significant proportion of hereditary breast and ovarian cancers (<a href="#B63" class="usa-link" aria-describedby="B63">Miki et al., 1994</a>; <a href="#B97" class="usa-link" aria-describedby="B97">Wooster et al., 1995</a>; <a href="#B27" class="usa-link" aria-describedby="B27">Ford et al., 1998</a>). It has been reported that the average cumulative risks in <em>BRCA1</em>-mutation carriers by age of 70 were 65% and 39% for breast and ovarian cancers respectively and the corresponding estimates for <em>BRCA2</em> were 45% and 11% (<a href="#B3" class="usa-link" aria-describedby="B3">Antoniou et al., 2003</a>). The frequency of germline mutations identified on the <em>BRCA</em> genes varies depending on the geographic and the ethnic distributions. Indeed, while most variations are shared between human populations, some of the <em>BRCA1/2</em> mutations are ethnic specific (<a href="#B26" class="usa-link" aria-describedby="B26">Fackenthal and Olopade, 2007</a>).</p>
<p>Since a good knowledge of population structure is essential for the development of efficient and individualized screening approaches, the identification of founder <em>BRCA</em> mutations is crucial to set up affordable and cost-effective breast cancer genetic testing. In North Africa, several <em>BRCA1/2</em> founder mutations were identified among which <em>BRCA1</em>-c.798_799delTT that was reported in 9.8% and 36.4% of familial and sporadic Algerian breast cancer cases, respectively (<a href="#B93" class="usa-link" aria-describedby="B93">Uhrhammer et al., 2008</a>). This same mutation was reported in Tunisian population with a frequency of 18% (<a href="#B56" class="usa-link" aria-describedby="B56">Mahfoudh et al., 2012</a>). Furthermore, <em>BRCA2-</em>c.1310_1313delAAGA is considered as a North African founder mutation since it has been identified in Algerian, Moroccan and Tunisian breast cancer cases (<a href="#B18" class="usa-link" aria-describedby="B18">Cherbal et al., 2010</a>; <a href="#B28" class="usa-link" aria-describedby="B28">Fourati et al., 2014</a>; <a href="#B47" class="usa-link" aria-describedby="B47">Laarabi et al., 2017</a>).</p>
<p>In Tunisia, founder mutations explain around 42% of hereditary disorders (<a href="#B78" class="usa-link" aria-describedby="B78">Romdhane et al., 2012</a>). This is mainly due to the high rates of consanguinity and endogamy. So far, few <em>BRCA1</em> deleterious mutations were identified in Tunisia and the most recurrent ones are c.211dupA and c.5266dupC (<a href="#B90" class="usa-link" aria-describedby="B90">Troudi et al., 2008</a>; <a href="#B56" class="usa-link" aria-describedby="B56">Mahfoudh et al., 2012</a>; <a href="#B28" class="usa-link" aria-describedby="B28">Fourati et al., 2014</a>; <a href="#B73" class="usa-link" aria-describedby="B73">Riahi et al., 2015</a>). <em>BRCA1</em>-c.5266dupC was originally described as an Ashkenazi founder mutation. Then, it has been reported in several other populations such as Russian, Italian, Slovenian, Greek and Tunisian (<a href="#B40" class="usa-link" aria-describedby="B40">Janavičius, 2010</a>). However, the c.211dupA mutation seems to be specific to Tunisia since it has never been previously described in any other population (<a href="#B91" class="usa-link" aria-describedby="B91">Troudi et al., 2007</a>).</p>
<p>Besides <em>BRCA1</em> and <em>BRCA2</em>, more than 100 loci are known to be associated with breast cancer risk (<a href="#B33" class="usa-link" aria-describedby="B33">Han et al., 2016</a>). For <em>BRCA</em> negative families, fine mapping of other high to moderate penetrant breast cancer genes is needed to explain the genetic predisposition to breast cancer. For this purpose, next generation sequencing technologies are widely used as a cost-effective approach for the detection of novel mutations (<a href="#B83" class="usa-link" aria-describedby="B83">Shahi et al., 2019</a>). Indeed, target gene sequencing (TGS), whole exome sequencing (WES), and whole genome sequencing (WGS) are the main protocols currently used to identify either new mutations or new candidate genes associated with hereditary disorders (<a href="#B17" class="usa-link" aria-describedby="B17">Chandler et al., 2016</a>; <a href="#B1" class="usa-link" aria-describedby="B1">Akter et al., 2019</a>; <a href="#B8" class="usa-link" aria-describedby="B8">Bewicke-Copley et al., 2019</a>; <a href="#B68" class="usa-link" aria-describedby="B68">Posey, 2019</a>; <a href="#B83" class="usa-link" aria-describedby="B83">Shahi et al., 2019</a>).</p>
<p>In the present study, we used classical as well as next generation sequencing technologies to investigate the genetic predisposition to breast cancer in 112 Tunisian families. Targeted mutation screening followed by target gene and whole exome sequencing were performed. We have also studied the founder effect and the relative age of the most frequent <em>BRCA1</em> mutation in Tunisia (c.211dupA). In addition, genotypic data were correlated to drug response, clinicopathological and phenotypic features of all mutation carriers.</p></section><section id="S2"><h2 class="pmc_sec_title">Materials and Methods</h2>
<section id="S2.SS1"><h3 class="pmc_sec_title">Patients</h3>
<p>A total of 122 individuals with strong familial history of breast cancer (111 patients and 11 healthy) were recruited from three principal medical oncology centers based in Tunis that provide care and services for Tunisian cancer patients from all over the country (Departments of Medical oncology of Abderrahmane Mami Hospital, of Military Hospital of Tunis and the surgical oncology Department of Institut Salah Azaiez). Prior to specimen collection, all participants signed written and informed consents and gave relevant information about their personal and familial cancer histories as well as their geographic origins. A patient was recruited if at least one of the following criteria is fulfilled: (1) Presence of at least two related first or second-degree breast cancer cases, (2) Breast cancer in young patients aged less than 36 years, (3) Presence of at least two cases of breast or ovarian cancer, regardless of age. The mean age at diagnosis of the whole studied cohort is 42.84 years. The geographic distribution of birth locations is as follows; the majority are originating from Northern Tunisia, however approximately 20% are from the Central region and 6% from the South region. Forty-three percent of patients have a strong family history of breast cancer where 2 or multiple family members were diagnosed with breast cancer. A family history of ovarian cancer was observed among approximately 10% of patients. Breast cancer patients selected for next generation sequencing are those with the strongest family history of breast cancer (having 2 or more cases) and/or with age at onset of less than 36 years.</p>
<p>Clinico-pathological characteristics and follow-up data have been collected from medical records of patients.</p></section><section id="S2.SS2"><h3 class="pmc_sec_title">Sanger Sequencing</h3>
<p>Total genomic DNA was isolated from peripheral blood using DNeasy blood DNA extraction Kit (Qiagen) according to the manufacturer’s instructions. DNA purity and concentration were measured using a NanoDrop<sup>TM</sup> spectrophotometer.</p>
<p>Polymerase chain reaction reactions were performed on genomic DNA, following standard protocols. Sanger sequencing was performed using an automated sequencer (ABI 3500; Applied Biosystems, Foster City, CA, United States) and a cycle sequencing reaction kit (Bigdye Terminator v3.1 kit, Applied Biosystems). Data was analyzed using BioEdit software version 7.2.5.</p>
<p>Sanger sequencing technique was first used to screen the c.211dupA mutation on exon 5 of <em>BRCA1</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.3</a>) among all 122 participants. It was also used to validate the identified variants resulting from the NGS assays. Non-carriers of c.211dupA mutation were tested for other recurrent <em>BRCA1/2</em> mutations in Tunisia namely <em>BRCA1-</em>c.798_799delTT, <em>BRCA1-</em>c.5266dupC, and <em>BRCA2-</em>c.1310_1313delAAGA (<a href="#B56" class="usa-link" aria-describedby="B56">Mahfoudh et al., 2012</a>; <a href="#B28" class="usa-link" aria-describedby="B28">Fourati et al., 2014</a>; <a href="#B64" class="usa-link" aria-describedby="B64">Msolly and Kassab, 2015</a>; <a href="#B73" class="usa-link" aria-describedby="B73">Riahi et al., 2015</a>).</p></section><section id="S2.SS3"><h3 class="pmc_sec_title">Targeted <em>BRCA1/2</em> Genes Sequencing</h3>
<p>Targeted <em>BRCA1/2</em> genes sequencing was performed for 9 patients. A DNA quantity of 40 ng measured by Qubit (Thermo Fisher Scientific, MA, United States) was used as a template to generate libraries for sequencing. Libraries were prepared using the QIAGEN Library Kit v2.0 and the GeneRead QIAact <em>BRCA1/2</em> panel (QIAGEN, Hilden, Germany), which comprises 253 pooled primer pairs custom designed to cover all coding regions of the <em>BRCA1</em> and <em>BRCA2</em> genes, including 20 bp flanking regions in adjacent introns. All steps of library preparation were performed according to the manufacturer’s protocol. The libraries were then quantified using a Qubit dsDNA HS Assay Kit (Life Technologies, MA, United States) and QIAxcel (QIAGEN, Hilden, Germany). Nine individual libraries were pooled prior to emulsion PCR and bead enrichment steps that were carried out using an automated protocol on the GeneRead QIAcube (QIAGEN, Hilden, Germany) using the GeneRead Clonal Amp Q Kit (QIAGEN, Hilden, Germany), according to the manufacturer’s protocol. Following bead enrichment, the pooled libraries were sequenced using the GeneReader platform (QIAGEN, Hilden, Germany).</p></section><section id="S2.SS4"><h3 class="pmc_sec_title">Whole Exome Sequencing (WES)</h3>
<p>Whole exome sequencing was performed for 8 patients. Samples were prepared according to Agilent SureSelect Protocol Version 1.2 and enrichment was carried out according to Agilent SureSelect protocols. Sequencing was performed on Illumina HiSeq2000 platform using TruSeq v3 chemistry with paired-end (2 × 100 pb). Exome DNA sequences were mapped to their location based on the hg19/b37 human genome using the Burrows–Wheeler Aligner (BWA) package (<a href="#B49" class="usa-link" aria-describedby="B49">Li and Durbin, 2009</a>). Duplicate reads were removed using Picard (<a href="#B25" class="usa-link" aria-describedby="B25">Ebbert et al., 2016</a>). The subsequent SAM files were converted to BAM files using Samtools (<a href="#B50" class="usa-link" aria-describedby="B50">Li et al., 2009</a>). GATK was then used to recalibrate the base quality scores as well as for SNP and short INDEL calling (<a href="#B60" class="usa-link" aria-describedby="B60">McKenna et al., 2010</a>).</p></section><section id="S2.SS5"><h3 class="pmc_sec_title">Functional Annotation and Variants Prioritization</h3>
<p>Annotation and prioritization of potential disease-causing variants were performed using VarAFT (Variant Annotation and Filtering Tool) 2.10 software (<a href="#B23" class="usa-link" aria-describedby="B23">Desvignes et al., 2018</a>). The annotated InDels and SNPs were filtered according to several criteria: (1) considering breast cancer as autosomal dominant disease, we removed variants that were found at homozygous state, (2) variants identified as intronic, intergenic and non-coding or synonymous were discarded, (3) assuming that causal variants are rare, we removed all variants with an allele frequency &gt; 1% either in 1000 Genomes or GnomAD_Exome databases, (4) benign or tolerated variants were discarded according to the following <em>in silico</em> prediction tools: Sorting Intolerant From Tolerant (SIFT), PolyPhen-2, Mutation Taster, LRT_pred and Combined Annotation Dependent Depletion CADD tool. We used SiPhy_log odds score calculated by ANNOVAR to keep deleterious variants with high scores and Gene Damage Index Prediction database (GDI) to exclude highly mutated genes.</p>
<p>The Wikipathways (<a href="#B86" class="usa-link" aria-describedby="B86">Slenter et al., 2017</a>) and Kyoto Encyclopedia of Genes and Genomes (KEGG) (<a href="#B42" class="usa-link" aria-describedby="B42">Kanehisa and Goto, 2000</a>) databases were used to assign genes to their pathways and the Network of Cancer Genes V 6.0 (<a href="#B72" class="usa-link" aria-describedby="B72">Repana et al., 2019</a>) was used to identify genes associated with cancers.</p></section><section id="S2.SS6"><h3 class="pmc_sec_title">Molecular Modeling</h3>
<p>We used the protein sequence of RAD50 annotated under the accession <a href="https://ncbi.nlm.nih.gov/nucleotide/Q92878" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Q92878</a> in the Uniprot database (<a href="#B20" class="usa-link" aria-describedby="B20">The Uniport Consortium, 2019</a>) as a reference sequence. To predict the 3D structure of the wild type RAD50 we used a comparative modeling approach with the satisfaction of spatial restraints using MODELLER version 9.22 (<a href="#B79" class="usa-link" aria-describedby="B79">Šali and Blundell, 1993</a>). Template identification consists of searching for homologous proteins to the RAD50 reference sequence in the Protein Data Bank (PDB) (<a href="#B7" class="usa-link" aria-describedby="B7">Berman et al., 2000</a>) using BLAST (identity sequence cutoff &gt; 30%) (<a href="#B2" class="usa-link" aria-describedby="B2">Altschul et al., 1990</a>).</p>
<p>The search for a template identified the structure of “DH domain-containing protein” from <em>Chaetomium thermophilum</em> (PDB code 5DAC) (<a href="#B80" class="usa-link" aria-describedby="B80">Seifert et al., 2016</a>) that shows a significant e-value of 4.2 e<sup>–72</sup> and a sequence identity of 50% (locally aligned) compared to hRAD50. The alignment of hRAD50 with the template covers 32% of the reference sequence including the position of the mutation. We introduced a distance restraint of 10 Å between the terminal residues of the coiled-coil segments belonging to the same monomer. Moreover, we built the model in the presence of ATPγS: Mg<sup>2+</sup> heteroatoms.</p>
<p>The template and target sequences were then aligned using ‘needle’ from the EMBOSS package (<a href="#B74" class="usa-link" aria-describedby="B74">Rice et al., 2000</a>) and the alignment was then edited manually to correct for errors. We then built the model by generating 50 conformers with different seeds using a rapid refinement protocol. The final model was selected based on the calculation of the DOPE score (<a href="#B84" class="usa-link" aria-describedby="B84">Shen and Sali, 2006</a>) and the quality assessment was checked by establishing the Ramachandran plot (<a href="#B53" class="usa-link" aria-describedby="B53">Lovell et al., 2003</a>) and the local energy profile Verify3D (<a href="#B54" class="usa-link" aria-describedby="B54">Lüthy et al., 1992</a>). The structure of the mutant p.Ala1216Gly was then built using the 3D model of the wild type based on MODELLER script that mutates and refines the protein structure.</p></section><section id="S2.SS7"><h3 class="pmc_sec_title">Stability Analysis</h3>
<p>We estimated the free energy of folding between the wild type and the mutant structure (ΔΔG<sub>Wt</sub><sub>–</sub><sub>Mut</sub>) using DynaMut (<a href="#B77" class="usa-link" aria-describedby="B77">Rodrigues et al., 2018</a>). Moreover, we performed a simulation of protein flexibility with CABS-flex 2.0 (<a href="#B39" class="usa-link" aria-describedby="B39">Jamroz et al., 2014</a>) for both the wild type and the mutant structures at a temperature of 1.6 (dimensionless value related to the physical temperature). For each protein, we performed four simulations with four different predefined seeds. The same set is used for the wild type and the mutant 3D structures. We run the simulation with a fully flexible backbone (protein-flexibility = 0), a number of Monte Carlo cycles of 100 (<em>y</em> = 100) and the protein restraints were reduced by a factor of 0.8. Root Mean Square Fluctuation (RMSF) value was analyzed by calculating the per residue one-tailed Welch’s <em>t</em>-test under the null hypothesis that the RMSF at a given position in the sequence does not differ between the mutant and the wild type and an alternative hypothesis being that the RMSF value at given position of the sequence is greater for the mutant than the wild type structure. The analysis was performed using an in-house python script that employs the Scipy library for scientific computing.</p></section><section id="S2.SS8"><h3 class="pmc_sec_title">Copy Number Variations Analysis</h3>
<p>Copy Number Variations (CNVs) calling was performed on WES data using the ExomeDepth R package (<a href="#B67" class="usa-link" aria-describedby="B67">Plagnol et al., 2012</a>). All CNVs were annotated using AnnotSV software (<a href="#B30" class="usa-link" aria-describedby="B30">Geoffroy et al., 2018</a>), a program designed for annotating and ranking Structural Variations (SV) from genomes. This tool compiles functionally, regulatory and clinically relevant information and aims to provide useful annotations to interpret SV potential pathogenicity. AnnotSV classifies CNVs into 5 classes (Class 1: benign, Class 2: likely benign, Class 3: VUS (Variant of Unknown Significance), Class 4: likely pathogenic, and Class 5: pathogenic). In order to identify the most relevant CNVs which may be associated with breast cancer risk, only CNVs classified as class 3, 4, and 5 were kept for further analysis. Biological pathways analysis has been performed using Wikipathways (<a href="#B86" class="usa-link" aria-describedby="B86">Slenter et al., 2017</a>) and KEGG (<a href="#B42" class="usa-link" aria-describedby="B42">Kanehisa and Goto, 2000</a>) datasets. Network of Cancer Genes V6.0 (<a href="#B72" class="usa-link" aria-describedby="B72">Repana et al., 2019</a>) was used to identify genes associated with cancers.</p></section><section id="S2.SS9"><h3 class="pmc_sec_title">Genotyping and Haplotype Analysis of c.211dupA Mutation</h3>
<p>Haplotype analysis was carried out for 39 individuals: six carriers of the c.211dupA mutation, 3 relatives, 15 breast cancer non-carriers, and 15 healthy age-matched Tunisian women from the general population. Four microsatellite markers (D17S800, D17S855 D17S902, and D17S806), spanning a 6.75 Mb region around the <em>BRCA1</em> gene were studied (<a href="#FS1" class="usa-link">Supplementary Figure 1</a>). Primers’ sequences were obtained from the Probe NCBI database and PCR conditions are available on request. PCR product size was evaluated by capillary electrophoresis on an ABI prism 3500 DNA Genetic Analyzer using the GeneMapper V.5.0 software (Applied Biosystems, Foster City, CA, United States). For the D17S806 marker, results were inconclusive, and it was excluded from further analysis. Haplotypes were then reconstructed using PHASE v.2.1 software (<a href="#B87" class="usa-link" aria-describedby="B87">Stephens et al., 2001</a>) that uses Bayesian methods to predict haplotype distribution.</p></section><section id="S2.SS10"><h3 class="pmc_sec_title">Estimation of c.211dupA Mutation Age</h3>
<p>The DMLE + 2.3 program (<a href="#B71" class="usa-link" aria-describedby="B71">Reeve and Rannala, 2002</a>) was used to estimate the age of the c.211dupA mutation. The DMLE input file included the full genotypes or haplotypes of probands and controls for the analyzed markers, chromosome map distances derived from the Marshfield sex-average genetic map, population growth rate per generation and an estimate of the proportion of disease chromosomes sampled. The other DMLE parameters were kept to their default values.</p>
<p>For the population growth rate (r), we used data from the Tunisian Institute of Statistics (INS<sup><a href="#footnote1" class="usa-link">1</a></sup>). This key parameter was estimated to be 1.348 per generation using the following formula: p<sub>1</sub> = p<sub>0</sub> × r<sup>g</sup>, where p<sub>1</sub> represents the Tunisian population size in 2014 (10.982.754), p<sub>0</sub> represents the Tunisian population in 1860 (1.1 million) (<a href="#B81" class="usa-link" aria-describedby="B81">Seklani, 1974</a>), and g is the number of generations between these two-time points.</p></section></section><section id="S3"><h2 class="pmc_sec_title">Results</h2>
<section id="S3.SS1"><h3 class="pmc_sec_title">Investigating the State of <em>BRCA1</em>-c.211dupA, Founder Effect and Age</h3>
<p>In the current study, 122 individuals from 112 Tunisian families with strong familial history of breast cancer were investigated using sanger and next generation sequencing. First, we looked for c.211dupA which is the most recurrent <em>BRCA1</em> mutation in the Tunisian population.</p>
<p>A total of 8 carriers of c.211dupA belonging to 5 unrelated families were identified. All carriers originated from the North-Eastern region of Tunisia. The relative frequency of this mutation is 12.2% (5 out of 41) and 4.46% (5 out of 112) in this region and in the whole cohort, respectively. <em>BRCA1</em>-c.211dupA seems to be the most frequent <em>BRCA</em> mutation in Tunisia, accounting for approximately 41% of all identified <em>BRCA1</em> mutations, if we consider this report and previous Tunisian studies (<a href="#B91" class="usa-link" aria-describedby="B91">Troudi et al., 2007</a>; <a href="#B28" class="usa-link" aria-describedby="B28">Fourati et al., 2014</a>; <a href="#B73" class="usa-link" aria-describedby="B73">Riahi et al., 2015</a>). In addition, we have not been able to identify any of the other recurrent mutations (<em>BRCA1</em>-c.798_799delTT, <em>BRCA1</em>-c.5266dupC, and <em>BRCA2</em>-c.1310_1313delAAGA) in the other non-carrier patients of the c.211dupA mutation.</p>
<p>To investigate the founder effect of c.211dupA, haplotype analysis was performed for 39 individuals. Results showed that 5 out of the 6 genotyped carriers shared an identical haplotype (170-145-147), corresponding to D17S800, D17S855, and D17S902 respectively and all carriers shared a common semi-haplotype (170-145) spanning a region of 2.15 Mb (1.08cM) on <em>BRCA1</em>. This haplotype was absent in non-carriers and was not found in control chromosomes. These results support the founder effect of the c.211dupA mutation in the North-East of Tunisia.</p>
<p>Given that the prevalence of <em>BRCA1</em> and <em>BRCA2</em> carriers in the Tunisian general population is not well defined, for the mutation age estimation, three separate analyses were performed, each using a different estimate for the proportion of sampled population carrying the c.211dupA mutation: 0.005, 0.01, and 0.015. Thus, the age estimates for c.211dupA mutation were approximately 6.5 generations (95% CI [5.2–8.8]), 6.3 generations (95% CI [4.7–8.5]), and 6.00 generations (95% CI [4.4–8.1]). Assuming a generation time of 20 years, the corresponding ages are 130 (95% CI [104–176]), 126 (95% CI [94–170]), and 120 (95% CI [88–162]) years.</p></section><section id="S3.SS2"><h3 class="pmc_sec_title">Clinico-Pathological Features and Follow-up of c.211dupA Mutation Carriers</h3>
<p>We further extended our analysis to the 9 additional carriers of c.211dupA mutation reported in previous Tunisian studies (<a href="#B91" class="usa-link" aria-describedby="B91">Troudi et al., 2007</a>; <a href="#B28" class="usa-link" aria-describedby="B28">Fourati et al., 2014</a>; <a href="#B73" class="usa-link" aria-describedby="B73">Riahi et al., 2015</a>). For a total of 15 c.211dupA carriers, the mean age at diagnosis was 39.41 years, ranging from 28 to 58 years (<a href="#T1" class="usa-link">Table 1</a>). Family history of breast cancer was observed in 93.33% cases (14/15) among which 20% (3/15) presented a family history of ovarian cancer. Other malignancies such as leukemia, prostate, colon and cervical cancers were observed in family members. Infiltrating ductal carcinoma (IDC) was the predominant tumor subtype, high grade 3 and axillary node involvement were observed in about 50% of carriers. The mean tumor size was 30 mm and 50% of carriers displayed a triple negative breast cancer (TNBC) phenotype with two additional cases harboring negative hormone receptors with unknown human epidermal growth factor receptor 2 (HER2) status. Thus, this mutation is likely associated with a severe phenotype.</p>
<section class="tw xbox font-sm" id="T1"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Clinico-pathological features of <em>BRCA1</em> and <em>RAD50</em> carriers.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups" cellspacing="5" cellpadding="5">
<thead><tr>
<td valign="top" align="left" rowspan="1" colspan="1">Carrier ID</td>
<td valign="top" align="left" rowspan="1" colspan="1">Pathology</td>
<td valign="top" align="left" rowspan="1" colspan="1">Age at diagnosis (years)</td>
<td valign="top" align="left" rowspan="1" colspan="1">Family History BC/OC</td>
<td valign="top" align="left" rowspan="1" colspan="1">Family history of other cancers</td>
<td valign="top" align="left" rowspan="1" colspan="1">Histological subtype</td>
<td valign="top" align="left" rowspan="1" colspan="1">SBR grade</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER status</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR status</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2 status</td>
<td valign="top" align="left" rowspan="1" colspan="1">Nodal status</td>
<td valign="top" align="left" rowspan="1" colspan="1">Tumor size (mm)</td>
<td valign="top" align="left" rowspan="1" colspan="1">Ki67-index (%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">Metastatic status</td>
<td valign="top" align="left" rowspan="1" colspan="1">Therapy</td>
<td valign="top" align="left" rowspan="1" colspan="1">Follow-up</td>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BC-TN-F009</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC and OC</td>
<td valign="top" align="left" rowspan="1" colspan="1">42, CBC at 63</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 BC/OC 1 OC</td>
<td valign="top" align="left" rowspan="1" colspan="1">Cervical cancer</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">−</td>
<td valign="top" align="left" rowspan="1" colspan="1">MCA, Adjuvant FEC-TXT, LRR</td>
<td valign="top" align="left" rowspan="1" colspan="1">OC 15 years after the 1st BC diagnosis. CBC after 21 years. Died 25 years after BC diagnosis.</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BC-TN-F0019</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">49</td>
<td valign="top" align="left" rowspan="1" colspan="1">3 BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">None</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">II</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER −</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR −</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">N−</td>
<td valign="top" align="left" rowspan="1" colspan="1">60</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">−</td>
<td valign="top" align="left" rowspan="1" colspan="1">MCA, Adjuvant chemo- therapy, LRR</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BC-TN-F0049-1</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">29 CBC at 32</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">Leukemia, Prostate, Colon, Gyneco- logical, Larynx</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">III</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER − ER +</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR− PR−</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2− HER2−</td>
<td valign="top" align="left" rowspan="1" colspan="1">N + N−</td>
<td valign="top" align="left" rowspan="1" colspan="1">35 38</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA 40</td>
<td valign="top" align="left" rowspan="1" colspan="1">−</td>
<td valign="top" align="left" rowspan="1" colspan="1">MCA, Adjuvant 4FEC, 4TXL-carboplatin, LRR</td>
<td valign="top" align="left" rowspan="1" colspan="1">Spontaneous pregnancy 6 months after the end of CT. CBC at 32 years old, 3 years after the 1<sup> st</sup> BC diagnosis. Adjuvant paclitaxel- carboplatin. Follow-up of 4 years.</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BC-TN-F0049-2</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">37</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">Leukemia, Prostate, Colon, Gyneco- logical, Larynx</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">III</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER +</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR +</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2−</td>
<td valign="top" align="left" rowspan="1" colspan="1">N +</td>
<td valign="top" align="left" rowspan="1" colspan="1">15</td>
<td valign="top" align="left" rowspan="1" colspan="1">2</td>
<td valign="top" align="left" rowspan="1" colspan="1">−</td>
<td valign="top" align="left" rowspan="1" colspan="1">MCA, Adjuvant 3FEC-9 weekly TXL, LRR, TAM and zoladex: 1 injection/month (18 injections)</td>
<td valign="top" align="left" rowspan="1" colspan="1">Patient in complete remission with a follow-up of 3 years</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BC-TN-F0093</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">34</td>
<td valign="top" align="left" rowspan="1" colspan="1">None</td>
<td valign="top" align="left" rowspan="1" colspan="1">Lung, pancreatic</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">II</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER −</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR −</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2−</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">30</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Died with disease progression.</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BC-TN-F199</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">58</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 BC 1 OC</td>
<td valign="top" align="left" rowspan="1" colspan="1">Endometrial, Lung</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">III</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER −</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR −</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2-</td>
<td valign="top" align="left" rowspan="1" colspan="1">N +</td>
<td valign="top" align="left" rowspan="1" colspan="1">40</td>
<td valign="top" align="left" rowspan="1" colspan="1">20</td>
<td valign="top" align="left" rowspan="1" colspan="1">+ (lung, bone)</td>
<td valign="top" align="left" rowspan="1" colspan="1">MCA, first-line CT: 6FEC, Cerebral RT,</td>
<td valign="top" align="left" rowspan="1" colspan="1">Lung and bone metastases. Progression after 3 cycles of FEC. Second-line CT: capecitabin during 5 months with objective response after 3 cycles. Cerebral metastasis. c.211dupA <em>BRCA1</em> mutation result Third-line CT 3 weekly carboplatin Died by disease progression 1 year after BC diagnosis.</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BC-TN-F204</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC and OC</td>
<td valign="top" align="left" rowspan="1" colspan="1">28</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 BC 2 OC</td>
<td valign="top" align="left" rowspan="1" colspan="1">Thyroid</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER −</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR −</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2−</td>
<td valign="top" align="left" rowspan="1" colspan="1">N−</td>
<td valign="top" align="left" rowspan="1" colspan="1">30</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">−</td>
<td valign="top" align="left" rowspan="1" colspan="1">TCA, Adjuvant FEC-TXT, LRR</td>
<td valign="top" align="left" rowspan="1" colspan="1">OC 13 years after BC. Complete surgery followed by adjuvant paclitaxel-carboplatin Patient in complete remission with a follow up of 16 years.</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">PEC-TN-F50-1</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">38</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">Lung, Pancreatic</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">II</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER −</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR−</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2−</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">30</td>
<td valign="top" align="left" rowspan="1" colspan="1">−</td>
<td valign="top" align="justify" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Newly diagnosed</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="attrib1"><p><em>BC, Breast Cancer; CBC, Contralateral Breast Cancer; CT, Chemotherapy; ER, Estrogen Receptor; FEC, 5-Fluorouracil-Epirubicin-Cyclophosmamide; HER2, Human Epidermal Growth Factor Receptor2; IDC, Invasive Ductal Carcinoma; LRR, LocoRegional Radiotherapy; MCA, Mastectomy; NA, Not Available; OC, Ovarian Cancer; PR, Progesterone Receptor; RT, Radiotherapy; SBR, Scarff-Bloom and Richardson; TAM; Tamoxifen; TCA, Tumorectomy; TXL, Paclitaxel; TXT, Docetaxel.</em></p></div></div></section><p>Assessment of disease evolution for c.211dupA carriers as well as their response to treatment were performed. Radical mastectomy was performed in 4 cases. Sequential adjuvant chemotherapy, 5-Fluorouracil-Epirubicin-Cyclophosphamide-Paclitaxel/Docetaxel (FEC-TXL/TXT) was administered to the majority of carriers and radiotherapy was performed in non-metastatic cases (<a href="#T1" class="usa-link">Table 1</a>). Two carriers (BC-TN-F204 and BC-TN-F009) have developed ovarian cancer 13 and 15 years after their breast cancer diagnosis respectively. Contralateral recurrence was observed in two cases (BC-TN-F009 and BC-TN-F0049-1). One patient diagnosed with triple negative metastatic breast cancer (BC-TN-F199) has a refractory disease treatment and died within 12 months by disease progression. However, the median survival of non-metastatic carriers was 12 years. We therefore concluded that except for the metastatic breast cancer case, chemotherapy treatments were well tolerated, and carriers had a good survival despite the severity of their clinico-pathological phenotype.</p></section><section id="S3.SS3"><h3 class="pmc_sec_title">BRCA1 and BRCA2 Variants Identified by Next-Generation Sequencing</h3>
<p>After studying the carriers of c.211dupA mutation in detail, we then selected 17 other breast cancer patients to be investigated by next generation sequencing. The selection was done on the basis of family history and disease onset. Targeted <em>BRCA1/2</em> sequencing and whole exome sequencing were performed on 9 and 8 breast cancer patients respectively. Familial pedigrees as well as phenotypic characteristics of all carriers are shown in <a href="#F1" class="usa-link">Figure 1</a> and <a href="#T1" class="usa-link">Table 1</a> respectively.</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">FIGURE 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7677579_fgene-11-552971-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e33e/7677579/e55e641f64bb/fgene-11-552971-g001.jpg" loading="lazy" height="447" width="759" alt="FIGURE 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Familial Pedigrees of <em>BRCA1</em> and <em>RAD50</em> mutations carriers. Available age at diagnosis of breast cancer cases is indicated between brackets. For some cases, only age at death was available and is indicated in square brackets. BOC, Breast and ovarian cancers; CBC, Contralateral breast cancer; IBC, Inflammatory breast cancer; OC, ovarian cancer. Black boxes mean breast cancer and half black boxes mean other cancer types.</p></figcaption></figure><p>The distribution of the identified <em>BRCA1/2</em> variations is illustrated in <a href="#F2" class="usa-link">Figure 2</a>. Exonic coding variants represented 27 out of 67 variants and based on ClinVar database, the majority of the identified <em>BRCA1/2</em> variants were classified as benign (58), 4 were classified as likely benign and 4 variants were not reported in ClinVar.</p>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">FIGURE 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7677579_fgene-11-552971-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e33e/7677579/659e777eeb6f/fgene-11-552971-g002.jpg" loading="lazy" height="197" width="790" alt="FIGURE 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Distribution of <em>BRCA1/2</em> variations identified in patients investigated by target gene and whole exome sequencing. <strong>(A)</strong> SNVs/InDels distribution, <strong>(B)</strong> Distribution of coding variations, <strong>(C)</strong> ClinVar classification of detected variations.</p></figcaption></figure><p>Additionally, our results identified a novel <em>BRCA1</em> pathogenic mutation on exon 11 (c.2418dupA and rs886040036) in one patient. This mutation has not been reported in previous studies neither in Tunisia nor in other populations. Nevertheless, it is already listed and classified as pathogenic in ClinVar and predicted to result in the substitution of Alanine to Serine (p.Ala807Serfs) followed by a premature truncation of BRCA1 protein at amino acid position 809.</p>
<p>Patient (BC-TN-F0093) harboring the c.2418dupA mutation is also originating from the North Eastern region of Tunisia. She was diagnosed with triple negative inflammatory breast cancer at 34 years old. Pathological examination of the tumor revealed invasive ductal carcinoma, Scarff-Bloom and Richardson (SBR) grade 2 with Ki-67 of 30%. No additional carriers of this mutation were found in the studied cohort.</p>
<p>The remaining 16 patients did not carry any pathogenic mutation on the <em>BRCA</em> genes.</p></section><section id="S3.SS4"><h3 class="pmc_sec_title">Whole Exome Sequencing Data Analysis</h3>
<section id="S3.SS4.SSS1"><h4 class="pmc_sec_title">Analysis of Known Breast Cancer Susceptibility Genes</h4>
<p>In our current study, in addition to the sanger sequencing analysis, and after screening for pathogenic <em>BRCA1/2</em> mutations among 17 breast cancer patients by NGS. We then selected a unique patient investigated by WES, originating from the North-East of Tunisia for detailed analysis, in order to shed light on the genetic architecture of breast cancer in this specific region. First, we looked for variations on 29 genes known to be associated with breast cancer. At this step we have identified a VUS on <em>RAD50</em>. Therefore, for this same patient, we extended our analysis in order to select other relevant variants on candidate genes that could be associated with malignancies based on <em>in silico</em> analysis and several genomic and biological pathways databases. The proband (BC-TN-F0019) was diagnosed with a locally advanced breast cancer at age 49 with negative hormone receptors status and SBR grade 2. Using whole exome data, we first investigated a list of 29 genes known to be associated with hereditary breast and ovarian cancers. Coverage analysis for these 29 genes demonstrated that we reached a depth of ∼50X and a percentage of coverage of 82% for the targeted regions (<a href="#TS1" class="usa-link">Supplementary Table 1</a>).</p>
<p>A total of 31 exonic variants and one splicing SNP were identified on the 29 genes (<a href="#TS2" class="usa-link">Supplementary Table 2</a>). None of these variants was classified as pathogenic in ClinVar. However, a VUS, c.3647C &gt; G, p.Ala1216Gly, was identified on <em>RAD50</em>. In the same patient, another variant, rs28908468, described by ClinVar as associated with “Drug response” (PARP inhibitors), was identified on <em>RAD51B.</em></p>
<p>We then made a detailed analysis of the mutation identified in the <em>RAD50</em> gene in order to investigate the possibility of revising its current classification in public databases such as ClinVar. Several <em>in silico</em> analysis, indeed, suggest the deleterious aspect of the RAD50 p.Ala1216Gly mutation.</p>
<p>To assess the putative effect of this mutation on RAD50 function, we performed a protein modeling and simulation analysis. First, we verified the conservation of the residue <em><a href="https://www.ncbi.nlm.nih.gov/protein/NP_005723.2" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_005723.2</a>: p.Ala1216</em> by establishing a multiple sequence alignment using homologous RAD50 proteins of model organisms (<a href="#F3" class="usa-link">Figure 3A</a>). We observed that <em>Ala1216</em> is located in a highly conserved segment found in all orthologous sequences belonging to organisms emerging at different evolution periods.</p>
<figure class="fig xbox font-sm" id="F3"><h5 class="obj_head">FIGURE 3.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7677579_fgene-11-552971-g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e33e/7677579/5c2990496adb/fgene-11-552971-g003.jpg" loading="lazy" height="536" width="800" alt="FIGURE 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Molecular modeling and stability analysis of RAD50_p.Ala1216Gly variation. <strong>(A)</strong> Multiple sequence alignment of hRAD50 with homologous proteins from model organisms, <em>Gorilla</em> (<a href="https://www.ncbi.nlm.nih.gov/protein/XP_004042521.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">XP_004042521.1</a>), <em>Mus musculus</em> (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_033038.2" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_033038.2</a>), <em>Gallus</em> (<a href="https://www.ncbi.nlm.nih.gov/protein/XP_414645.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">XP_414645.3</a>), <em>Xenopus laevis</em> (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_001154855.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_001154855.1</a>), <em>Danio rerio</em> (<a href="https://www.ncbi.nlm.nih.gov/protein/XP_005167995.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">XP_005167995.1</a>), <em>Anolis carolinensis</em> (<a href="https://www.ncbi.nlm.nih.gov/protein/XP_003217435.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">XP_003217435.1</a>) and <em>Drosophila melanogaster</em> (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_001246461.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_001246461.1</a>). <strong>(B)</strong> Predicted 3D structure of hRAD50 predicted with comparative modeling showing the mutation site and the different domains of the protein. DNA docking was generated by transferring the coordinates of the nucleic acid after a structural superposition of the symmetric chains. <strong>(C)</strong> Position of the mutation A1216G on the ATPγS:Mg ++ stabilizing α-helix extended over residues 1203-1221. <strong>(D)</strong> Comparative RMSF analysis between the reference protein (A1216, solid lines) and the mutated protein (G1216, dashed lines). The values of RMSF for the reference protein were shifted to +3 Å. For the sake of visibility. The green dots represent the position where p-values are significant at a confidence level α = 0.05.</p></figcaption></figure><p>Next, we constructed a homology model of RAD50. The predicted 3D model of hRAD50 consists of the assembly into a homodimer (<a href="#F3" class="usa-link">Figure 3B</a>). Each monomer covers segments 2-221 and 1098-1315 which include a relatively small coiled-coil region and the Walker A and Walker B globular domains. The assembly of the latter contains the Protein-DNA interface and the interaction surface with MRE11. The Stereochemical and the local energy quality were validated for the predicted model in comparison with the template structure (<a href="#FS2" class="usa-link">Supplementary Figure 2</a>).</p>
<p>The mutation site is situated in the core of hRAD50 as part of an α helix extended over residues 1203-1221 (<a href="#F3" class="usa-link">Figures 3B,C</a>). Residue A1216 establishes a hydrophobic contact with I1146 situated on another α-helix with a Cα-Cα distance of 5.7 Å. The mutation p.Ala1216Gly is able to preserve this hydrophobic contact. The N-terminal end of the α-helix stabilizes both the Mg<sup>2+</sup> and the ATPγS particularly, the thiotriphosphate moiety of the substrate. The calculation of ΔΔG<sub>Wt</sub><sub>–</sub><sub>Mut</sub> predicted a destabilizing effect for all five methods, DynaMut, ENCoM, mCSM, SDM and DUET with values of -0.037, -0.416, -1.4, -2.170, -1.643 kcal.mol<sup>–1</sup> respectively. Moreover, ENCoM predicted a vibrational entropy energy of 0.52 kcal.mol<sup>–1</sup>.K<sup>–1</sup> suggesting an increase of the molecular flexibility.</p>
<p>Because a substitution to glycine may affect the flexibility of other regions in the protein, the extent of this mutation was evaluated by simulating hRAD50 using CABS-flex approach (<a href="#F3" class="usa-link">Figure 3D</a>). Our results suggest a significant increase in the RMSF values at a confidence level of 5% (Green dots of <a href="#F3" class="usa-link">Figure 3D</a>) for 71 positions located on both monomers. Of these, residues P165, L166, S1210, I1213 seems to be the most critical as they belong to the helix harboring the mutation (S1210, I1213) or are in the proximity of ATPγS: Mg<sup>2+</sup> interaction site (P165, L166). Interestingly, the flexibility does also increase for several amino acids that belong to the surface patch involved in the interaction with MRE11 (<a href="#B80" class="usa-link" aria-describedby="B80">Seifert et al., 2016</a>). These residues are: F28, L31, V89, N90, G91, K112, T113, L114, E115, G116, I119 of Walker A and D1272, D1295, Q1296, C1297, S1298, K1301, C1302, S1303, V1304 of Walker B.</p></section><section id="S3.SS4.SSS2"><h4 class="pmc_sec_title">Identification of Novel Candidate Variants</h4>
<p>In addition to the 29 genes known to be associated with breast cancer, we investigated all the other variants resulting from WES analysis. In order to identify the relevant variants that could be associated with malignancies, we used several <em>in silico</em> prediction tools, genomic databases, biological pathways databases and we performed a literature review. Eleven variants in 11 genes were identified of which 2 candidate variants have been submitted in the ClinVar database. The remaining variants were not reported in the ClinVar database and therefore, their pathogenicity is still not documented. For this, functional and association studies are needed to verify that.</p>
<p>A total of 61,404 heterozygous variants were identified (<a href="#F4" class="usa-link">Figure 4</a>). Among them, 6773 relevant variants (exonic, splicing, non-synonymous, frameshift Indels, stopgain and stoploss) were identified. Variants with MAF &gt; 1% in 1000 Genomes and gnomAD_Exome databases were excluded. Therefore, 677 rare variations were selected for further investigations. In order to select the most relevant SNPs, several <em>in silico</em> prediction tools and databases were used as described in the methods section. A list of 33 non-synonymous variants belonging to 33 genes were retained.</p>
<figure class="fig xbox font-sm" id="F4"><h5 class="obj_head">FIGURE 4.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7677579_fgene-11-552971-g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e33e/7677579/7b330fe4b9fb/fgene-11-552971-g004.jpg" loading="lazy" height="353" width="760" alt="FIGURE 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/F4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Variants prioritization. Total variations: represents the total number of the identified heterozygous variants and CNVs. Rare relevant variants: we kept (exonic, splicing, non-synonymous, frameshift Indels, stop gain, stop loss) variants. We excluded variants with a frequency &gt; 1% in 1000 genomes and gnomAD_Exome databases and CNVs with a frequency &gt; 1% in DGV. Functional prediction: using several prediction tools: SIFT (Deleterious), PolyPhen2 (Probably damaging), Mutation Taster (disease-causing), LRT_pred (Deleterious), CADD (score ≥ 15), SiPhy_29way_logOdds (score &gt; 16), GDI database (excluding highly mutated genes). Using AnnotSV only CNVs (VUS, likely pathogenic or pathogenic) are kept. Biological pathways investigation and selection of candidate variants and CNVs disrupting cancer genes: Using wikipathways, KEGG databases, network of cancer genes 6.0 database and literature review.</p></figcaption></figure><p>These 33 genes were further filtered based on their implication in cancer etiology using Network of Cancer Genes V6.0. The list of genes was compared to those listed in Wikipathways and KEGG datasets as belonging to pathways relevant in cancers. In addition, we performed a literature review to identify genes more likely to be involved in malignancies development.</p>
<p>Based on these analyses, 11 genes were selected, namely <em>MITF, COL7A1, FOXM1, TSHZ2, AMOTL2, ANKS6, ACACB, LIPE, SNRK, CACNA2D3</em>, and <em>SMG1</em> (<a href="#T2" class="usa-link">Table 2</a>). Among all variants identified on these genes, two variants, namely <em>ANKS6</em>_rs199722684 and <em>MITF</em>_rs149617956 have been classified in ClinVar as a VUS and a variant with “conflicting interpretations of pathogenicity,” respectively.</p>
<section class="tw xbox font-sm" id="T2"><h5 class="obj_head">TABLE 2.</h5>
<div class="caption p"><p>Candidate variations identified in whole exome sequenced breast cancer patient.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups" cellspacing="5" cellpadding="5">
<thead>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Chromosome-Position<sup>1</sup>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">Gene</td>
<td valign="top" align="left" rowspan="1" colspan="1">Reference sequence</td>
<td valign="top" align="left" rowspan="1" colspan="1">Coding Change</td>
<td valign="top" align="left" rowspan="1" colspan="1">Protein variation</td>
<td valign="top" align="left" rowspan="1" colspan="1">Variant Id</td>
<td valign="top" align="center" rowspan="1" colspan="1">Frequency</td>
<td valign="top" align="center" rowspan="1" colspan="1">Frequency (gnom_AD_exome_ALL)</td>
<td rowspan="1" colspan="1"></td>
<td valign="top" align="center" colspan="6" rowspan="1">Prediction tools</td>
<td valign="top" align="left" rowspan="1" colspan="1">Affected pathways</td>
<td valign="top" align="left" rowspan="1" colspan="1">NCG</td>
<td valign="top" align="left" rowspan="1" colspan="1">Literature review</td>
</tr>
<tr>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td valign="top" align="left" colspan="2" rowspan="1"><hr></td>
<td rowspan="1" colspan="1"></td>
<td valign="top" align="left" colspan="8" rowspan="1"><hr></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">dbSNP</td>
<td valign="top" align="center" rowspan="1" colspan="1">(1000 genomes)</td>
<td rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">SIFT</td>
<td valign="top" align="center" rowspan="1" colspan="1">Poly phen2</td>
<td valign="top" align="center" rowspan="1" colspan="1">Mutation taster</td>
<td valign="top" align="center" rowspan="1" colspan="1">LRT_pred</td>
<td valign="top" align="center" rowspan="1" colspan="1">CADD_phred</td>
<td valign="top" align="center" rowspan="1" colspan="1">SiPhy_29way_logOdds</td>
<td valign="top" align="left" rowspan="1" colspan="1">ClinVar</td>
<td valign="top" align="left" rowspan="1" colspan="1">Wikipathways/KEGG</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Chr3: 43389157</td>
<td valign="top" align="left" rowspan="1" colspan="1"><em>SNRK</em></td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001100594" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_001100594</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">c.1406G &gt; A</td>
<td valign="top" align="left" rowspan="1" colspan="1">p.R469Q</td>
<td valign="top" align="left" rowspan="1" colspan="1">rs3719 00831</td>
<td valign="top" align="center" rowspan="1" colspan="1">−</td>
<td valign="top" align="center" rowspan="1" colspan="1">6.514e-05</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">25.2</td>
<td valign="top" align="center" rowspan="1" colspan="1">17.90</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">−/−</td>
<td valign="top" align="left" rowspan="1" colspan="1">Cancer gene (Mucosal melanoma)</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>SNRK</em> inhibited colon cancer cell proliferation (<a href="#B76" class="usa-link" aria-describedby="B76">Rines et al., 2012</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Chr3: 48602299</td>
<td valign="top" align="left" rowspan="1" colspan="1"><em>COL7A1</em></td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000094" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000094</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">c.8735G &gt; A</td>
<td valign="top" align="left" rowspan="1" colspan="1">p.C2912Y</td>
<td valign="top" align="center" rowspan="1" colspan="1">−</td>
<td valign="top" align="center" rowspan="1" colspan="1">−</td>
<td valign="top" align="center" rowspan="1" colspan="1">−</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">25.7</td>
<td valign="top" align="center" rowspan="1" colspan="1">18.23</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">−/Protein digestion and absorption</td>
<td valign="top" align="left" rowspan="1" colspan="1">Cancer gene (Chronic myeloid leukemia)</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>COL7A1</em> is mutated and a candidate tumor suppressor gene in breast cancer. Its hypermethylation in breast cancer is correlated with a poor prognosis (<a href="#B96" class="usa-link" aria-describedby="B96">Wood et al., 2007</a>; <a href="#B16" class="usa-link" aria-describedby="B16">Chan et al., 2008</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Chr3: 54925426</td>
<td valign="top" align="left" rowspan="1" colspan="1"><em>CACNA2D3</em></td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_018398" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_018398</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">c.2195C &gt; T</td>
<td valign="top" align="left" rowspan="1" colspan="1">p.T732M</td>
<td valign="top" align="left" rowspan="1" colspan="1">rs1123 62995</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.003</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.0078</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">34</td>
<td valign="top" align="center" rowspan="1" colspan="1">17.65</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">MAPK signaling pathway</td>
<td valign="top" align="center" rowspan="1" colspan="1">−</td>
<td valign="top" align="left" rowspan="1" colspan="1">CACNA2D3 was downregulated in esophageal squamous cell carcinoma, nasopharyngeal carcinomas and gliomas (<a href="#B51" class="usa-link" aria-describedby="B51">Li et al., 2013</a>; <a href="#B94" class="usa-link" aria-describedby="B94">Wong et al., 2013</a>; <a href="#B41" class="usa-link" aria-describedby="B41">Jin et al., 2017</a>) and has an antitumor role in endometrial cancer (<a href="#B45" class="usa-link" aria-describedby="B45">Kong et al., 2020</a>).</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Chr3: 70014091</td>
<td valign="top" align="left" rowspan="1" colspan="1"><em>MITF</em></td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000248" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000248</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">c.952G &gt; A</td>
<td valign="top" align="left" rowspan="1" colspan="1">p.E318K</td>
<td valign="top" align="left" rowspan="1" colspan="1">rs149 617956</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.0007</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.0014</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">27.9</td>
<td valign="top" align="center" rowspan="1" colspan="1">20.87</td>
<td valign="top" align="left" rowspan="1" colspan="1">Conflicting pathogenicity</td>
<td valign="top" align="left" rowspan="1" colspan="1">RANKL/RANK and Kit receptor signaling pathway/Melanoma, Transcriptional misregulation in cancer, Pathways in cancer</td>
<td valign="top" align="left" rowspan="1" colspan="1">Cancer gene (TNBC)</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>MITF</em> is associated with several cancers. E318K-<em>MITF</em> variant is very rare in breast cancer patients (<a href="#B32" class="usa-link" aria-describedby="B32">Gromowski et al., 2014</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Chr3: 134090187</td>
<td valign="top" align="left" rowspan="1" colspan="1"><em>AMOTL2</em></td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001278683" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_001278683</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">c.263C &gt; T</td>
<td valign="top" align="left" rowspan="1" colspan="1">p.T88M</td>
<td valign="top" align="left" rowspan="1" colspan="1">rs2003 36077</td>
<td valign="top" align="center" rowspan="1" colspan="1">−</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.0001</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">26</td>
<td valign="top" align="center" rowspan="1" colspan="1">17.85</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">−/Tight junction</td>
<td valign="top" align="center" rowspan="1" colspan="1">−</td>
<td valign="top" align="left" rowspan="1" colspan="1">Amot family members promote the proliferation and invasion of cancer cells, including breast, colon, prostate, cervical, liver, and renal cell cancer (<a href="#B55" class="usa-link" aria-describedby="B55">Lv et al., 2017</a>).</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Chr9: 101518761</td>
<td valign="top" align="left" rowspan="1" colspan="1"><em>ANKS6</em></td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_173551" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_173551</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">c.2267C &gt; T</td>
<td valign="top" align="left" rowspan="1" colspan="1">p.S756L</td>
<td valign="top" align="left" rowspan="1" colspan="1">rs1997 22684</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.0001</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.0005</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">34</td>
<td valign="top" align="center" rowspan="1" colspan="1">16.37</td>
<td valign="top" align="left" rowspan="1" colspan="1">VUs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Ciliary landscape/−</td>
<td valign="top" align="center" rowspan="1" colspan="1">−</td>
<td valign="top" align="left" rowspan="1" colspan="1">SNPs in ANKS6 were nominally significantly associated with breast cancer (<a href="#B37" class="usa-link" aria-describedby="B37">Higginbotham et al., 2012</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Chr12: 2968078</td>
<td valign="top" align="left" rowspan="1" colspan="1"><em>FOXM1</em></td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001243088" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_001243088</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">c.1973C &gt; T</td>
<td valign="top" align="left" rowspan="1" colspan="1">p.P658L</td>
<td valign="top" align="left" rowspan="1" colspan="1">rs289 19870</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.004</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.0064</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">26.8</td>
<td valign="top" align="center" rowspan="1" colspan="1">16.86</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">DNA IR-damage and cellular response via ATR, Epithelial to mesenchymal transition in colorectal cancer/Cellular senescence.</td>
<td valign="top" align="left" rowspan="1" colspan="1">Cancer gene (multiple cancers)</td>
<td valign="top" align="left" rowspan="1" colspan="1">Over-expression of FOXM1 is indicative of poor prognosis in breast cancer patients (<a href="#B6" class="usa-link" aria-describedby="B6">Bektas et al., 2008</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Chr12: 109625861</td>
<td valign="top" align="left" rowspan="1" colspan="1"><em>ACACB</em></td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001093" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_001093</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">c.2038G &gt; A</td>
<td valign="top" align="left" rowspan="1" colspan="1">p.V680M</td>
<td valign="top" align="left" rowspan="1" colspan="1">rs2015 20813</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.0001</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.438e-05</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">33.0</td>
<td valign="top" align="center" rowspan="1" colspan="1">18.61</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">AMPK and leptin signaling pathway. Pathways in clear cell renal cell carcinoma VEGFA-VEGFR2 Signaling Pathway/Fatty acid biosynthesis</td>
<td valign="top" align="center" rowspan="1" colspan="1">−</td>
<td valign="top" align="left" rowspan="1" colspan="1">ACACB was downregulated in breast cancer and positively associated with survival time (<a href="#B5" class="usa-link" aria-describedby="B5">Bai et al., 2019</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Chr16: 18860605</td>
<td valign="top" align="left" rowspan="1" colspan="1"><em>SMG1</em></td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_015092" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_015092</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">c.5557C &gt; G</td>
<td valign="top" align="left" rowspan="1" colspan="1">p.P1853A</td>
<td valign="top" align="left" rowspan="1" colspan="1">rs7720 66609</td>
<td valign="top" align="center" rowspan="1" colspan="1">−</td>
<td valign="top" align="center" rowspan="1" colspan="1">4.875e-05</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">23.2</td>
<td valign="top" align="center" rowspan="1" colspan="1">18.74</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">−/mRNA surveillance pathway</td>
<td valign="top" align="left" rowspan="1" colspan="1">Cancer gene (multiple cancers)</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>SMG1</em> gene known to be associated with pancreatic cancer risk (<a href="#B95" class="usa-link" aria-describedby="B95">Wong et al., 2019</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Chr19: 42914772</td>
<td valign="top" align="left" rowspan="1" colspan="1"><em>LIPE</em></td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005357" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_005357</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">c.1106C &gt; T</td>
<td valign="top" align="left" rowspan="1" colspan="1">p.P369L</td>
<td valign="top" align="left" rowspan="1" colspan="1">rs1385 39064</td>
<td valign="top" align="center" rowspan="1" colspan="1">−</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.0006</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">26.5</td>
<td valign="top" align="center" rowspan="1" colspan="1">16.32</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Focal Adhesion-PI3K-Akt-mTOR/AMPK signaling pathway</td>
<td valign="top" align="center" rowspan="1" colspan="1">−</td>
<td valign="top" align="left" rowspan="1" colspan="1">A significant positive correlation with LIPE was observed in BRCA, colorectal and prostate carcinomas) (<a href="#B65" class="usa-link" aria-describedby="B65">Nath and Chan, 2016</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Chr20: 51870682</td>
<td valign="top" align="left" rowspan="1" colspan="1"><em>TSHZ2</em></td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001193421" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_001193421</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">c.676G &gt; A</td>
<td valign="top" align="left" rowspan="1" colspan="1">p.E226K</td>
<td valign="top" align="left" rowspan="1" colspan="1">rs3755 70590</td>
<td valign="top" align="center" rowspan="1" colspan="1">−</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.031e-05</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">D</td>
<td valign="top" align="center" rowspan="1" colspan="1">25.5</td>
<td valign="top" align="center" rowspan="1" colspan="1">19.09</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">−/−</td>
<td valign="top" align="left" rowspan="1" colspan="1">Cancer gene (multiple cancers)</td>
<td valign="top" align="left" rowspan="1" colspan="1">TSHZ2, known to be down-regulated in breast and prostate cancers (<a href="#B75" class="usa-link" aria-describedby="B75">Riku et al., 2016</a>)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="attrib2"><p><em>LRT_pred_D, Deleterious; Mutation taster_D, Disease causing; NA, Non available; Polyphen2_D, Probably damaging; SIFT_D, Deleterious; VUS, Variant with Uncertain Significance. <sup>1</sup>Mean chromosome positionis mentioned according to the assembly GRCh37/hg19.</em></p></div></div></section></section><section id="S3.SS4.SSS3"><h4 class="pmc_sec_title">Copy Number Variations Analysis</h4>
<p>Copy number variations were also investigated in order to assess their possible contribution to disease susceptibility (<a href="#F4" class="usa-link">Figure 4</a>). Fifty-one CNVs including 30 deletions and 21 duplications were identified with an average size of 24.2 kb (ranging from 64 bp to 123918 bp). Only rare (&lt; 1%) and relevant CNVs (of unknown significance, likely pathogenic or pathogenic and ranked as class 3, class 4, and class 5 respectively based on AnnotSV) were kept (<a href="#F4" class="usa-link">Figure 4</a>).</p>
<p>A total of 7 CNVs affecting 11 genes were identified. Biological pathways analysis has been also performed to select genes linked to breast cancer etiology. In addition, we searched published literature regarding genes affected by CNVs and breast cancer risk (<a href="#T3" class="usa-link">Table 3</a>). Among the 11 genes, 5 had been previously identified as cancer genes or candidate cancer genes namely <em>TMTC3, BCL3, COL7A1, RNF5</em>, and <em>CEP290.</em></p>
<section class="tw xbox font-sm" id="T3"><h5 class="obj_head">TABLE 3.</h5>
<div class="caption p"><p>Candidate rare Copy Number Variations likely associated with cancers.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups" cellspacing="5" cellpadding="5">
<thead>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Chromosome</td>
<td valign="top" align="center" rowspan="1" colspan="1">Start</td>
<td valign="top" align="center" rowspan="1" colspan="1">End</td>
<td valign="top" align="center" rowspan="1" colspan="1">CNV length</td>
<td valign="top" align="center" rowspan="1" colspan="1">CNV type</td>
<td valign="top" align="center" rowspan="1" colspan="1">Genes</td>
<td valign="top" align="center" colspan="2" rowspan="1">Affected Pathways<hr>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">Network of Cancer genes annotation</td>
<td valign="top" align="center" rowspan="1" colspan="1">DGV Frequency</td>
<td valign="top" align="center" rowspan="1" colspan="1">AnnotSV ranking</td>
<td valign="top" align="left" rowspan="1" colspan="1">Literature review</td>
</tr>
<tr>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Wikipathways</td>
<td valign="top" align="left" rowspan="1" colspan="1">KEGG</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">3</td>
<td valign="top" align="center" rowspan="1" colspan="1">48612641</td>
<td valign="top" align="center" rowspan="1" colspan="1">48612972</td>
<td valign="top" align="center" rowspan="1" colspan="1">-331</td>
<td valign="top" align="center" rowspan="1" colspan="1">DEL</td>
<td valign="top" align="center" rowspan="1" colspan="1"><em>COL7A1</em></td>
<td valign="top" align="center" rowspan="1" colspan="1">−</td>
<td valign="top" align="left" rowspan="1" colspan="1">Protein digestion and absorption</td>
<td valign="top" align="left" rowspan="1" colspan="1">Chronic myeloid leukemia</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.00017</td>
<td valign="top" align="center" rowspan="1" colspan="1">4</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>COL7A1</em> gene is mutated and a candidate tumor suppressor gene in breast cancer. Hypermethylation of COL7A1 in breast cancer resulted in loss of ColVII expression in tumors correlating with a poor prognosis (<a href="#B96" class="usa-link" aria-describedby="B96">Wood et al., 2007</a>; <a href="#B16" class="usa-link" aria-describedby="B16">Chan et al., 2008</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">6</td>
<td valign="top" align="center" rowspan="1" colspan="1">32147655</td>
<td valign="top" align="center" rowspan="1" colspan="1">32147903</td>
<td valign="top" align="center" rowspan="1" colspan="1">248</td>
<td valign="top" align="center" rowspan="1" colspan="1">DUP</td>
<td valign="top" align="center" rowspan="1" colspan="1"><em>RNF5</em></td>
<td valign="top" align="center" rowspan="1" colspan="1">−</td>
<td valign="top" align="left" rowspan="1" colspan="1">Protein processing in endoplasmic reticulum</td>
<td valign="top" align="center" rowspan="1" colspan="1">−</td>
<td valign="top" align="center" rowspan="1" colspan="1">−</td>
<td valign="top" align="center" rowspan="1" colspan="1">4</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>RNF5</em> is involved in the control of breast cancer progression and in survival of breast cancer patients (<a href="#B12" class="usa-link" aria-describedby="B12">Bromberg et al., 2007</a>). Ubiquitin ligase RNF5 serves an important role in the development of human glioma. RNF5 was significantly associated with diagnosis and prognosis of Hepatocellular carcinoma (<a href="#B98" class="usa-link" aria-describedby="B98">Zhu et al., 2016</a>; <a href="#B29" class="usa-link" aria-describedby="B29">Gao et al., 2019</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">12</td>
<td valign="top" align="center" rowspan="1" colspan="1">88512261</td>
<td valign="top" align="center" rowspan="1" colspan="1">88554006</td>
<td valign="top" align="center" rowspan="1" colspan="1">41745</td>
<td valign="top" align="center" rowspan="1" colspan="1">DUP</td>
<td valign="top" align="center" rowspan="1" colspan="1"><em>CEP290, TMTC3</em></td>
<td valign="top" align="left" rowspan="1" colspan="1">Pathways in clear cell renal cell carcinoma</td>
<td valign="top" align="center" rowspan="1" colspan="1">−</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>(TMTC3</em><strong>)</strong> A candidate cancer gene mutated in Pancreatic cancer</td>
<td valign="top" align="center" rowspan="1" colspan="1">−</td>
<td valign="top" align="center" rowspan="1" colspan="1">4</td>
<td valign="top" align="center" rowspan="1" colspan="1">−</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">19</td>
<td valign="top" align="center" rowspan="1" colspan="1">45261982</td>
<td valign="top" align="center" rowspan="1" colspan="1">45262872</td>
<td valign="top" align="center" rowspan="1" colspan="1">-890</td>
<td valign="top" align="center" rowspan="1" colspan="1">DEL</td>
<td valign="top" align="center" rowspan="1" colspan="1"><em>BCL3</em></td>
<td valign="top" align="left" rowspan="1" colspan="1">Apoptosis-related network due to altered Notch3 in ovarian cancer</td>
<td valign="top" align="left" rowspan="1" colspan="1">C-type lectin receptor signaling pathway TNF signaling pathway</td>
<td valign="top" align="left" rowspan="1" colspan="1">Hepatobiliary (Cholangiocarcinoma)</td>
<td valign="top" align="center" rowspan="1" colspan="1">−</td>
<td valign="top" align="center" rowspan="1" colspan="1">4</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>BCL3</em> participates in progression of diverse solid tumors (<a href="#B57" class="usa-link" aria-describedby="B57">Maldonado and Melendez-Zajgla, 2011</a>)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="attrib3"><p><em>AnnotSV ranking: 4 Likely Pathogenic.</em></p></div></div></section></section></section></section><section id="S4"><h2 class="pmc_sec_title">Discussion</h2>
<p>Since their discovery in 1994 and 1995, a wide range of mutational spectrum have been described for <em>BRCA1</em> and <em>BRCA2</em> genes (<a href="#B48" class="usa-link" aria-describedby="B48">Laraqui et al., 2015</a>). Several recurrent mutations have been reported in the Tunisian population. Some of these mutations are specific to Tunisians, others are shared with neighboring populations (<a href="#B90" class="usa-link" aria-describedby="B90">Troudi et al., 2008</a>; <a href="#B56" class="usa-link" aria-describedby="B56">Mahfoudh et al., 2012</a>; <a href="#B28" class="usa-link" aria-describedby="B28">Fourati et al., 2014</a>; <a href="#B64" class="usa-link" aria-describedby="B64">Msolly and Kassab, 2015</a>; <a href="#B73" class="usa-link" aria-describedby="B73">Riahi et al., 2015</a>). So far, <em>BRCA1</em>-c.211dupA mutation has been reported only in Tunisian families with breast cancer (<a href="#B91" class="usa-link" aria-describedby="B91">Troudi et al., 2007</a>; <a href="#B28" class="usa-link" aria-describedby="B28">Fourati et al., 2014</a>; <a href="#B73" class="usa-link" aria-describedby="B73">Riahi et al., 2015</a>). In the present report, 8 carriers of c.211dupA were identified, all originating from the North-East of Tunisia, suggesting that this mutation is specific to this region. This finding is in agreement with the results of Riahi and colleagues where all carriers of the c.211dupA mutation were all originating from the North-Eastern region of Tunisia (<a href="#B73" class="usa-link" aria-describedby="B73">Riahi et al., 2015</a>).</p>
<p>In order to unravel the genetic specificities of this mutation and to trace its origin, a haplotype analysis was conducted and results support the founder effect of c.211dupA mutation in the North-East of Tunisia. We have also estimated the <em>BRCA1-</em>c.211dupA approximative age. Indeed, it seems that this mutation appeared 130 years ago in Tunisia, during the second half of the 19th century and after the French occupation that took place in 1881. All migratory waves that occurred at the colonial period may be at the origin of new mutations and had therefore a considerable impact on the genetic diversity of the Tunisian population.</p>
<p>The recent origin and the limited geographical distribution of this mutation may also suggest that it could be a <em>de novo</em> mutation that occurred in the 19th century in an individual from the North East of Tunisia. Despite the high rates of <em>de novo</em> mutation that have been observed in several other genes, only 15 carriers of <em>de novo BRCA1/2</em> mutations have been reported to date (<a href="#B31" class="usa-link" aria-describedby="B31">Golmard et al., 2016</a>).</p>
<p>Furthermore, investigation of clinicopathological features of c.211dupA carriers showed that the majority exhibited high histological tumor grade and were diagnosed with TNBC. Our findings are in agreement with previous studies reporting that breast carcinomas in <em>BRCA1</em> mutation carriers are associated with aggressive tumor characteristics (<a href="#B4" class="usa-link" aria-describedby="B4">Armes et al., 1998</a>). Additionally, the TNBC phenotype is the most observed molecular subtype in patients with <em>BRCA1</em> mutation and it is well documented that breast cancer patients with <em>BRCA1</em> mutation are significantly associated with worse overall survival than patients with a non-mutated <em>BRCA1</em> allele (pooled HR = 1.69 (95% CI 1.35 to 2.12, <em>p</em> &lt; 0.001; <em>I</em><sup>2</sup> = 59.1%) (<a href="#B98" class="usa-link" aria-describedby="B98">Zhu et al., 2016</a>). Nevertheless, in the present study, median survival of non-metastatic carriers of c.211dupA mutation was 12 years.</p>
<p>We have also investigated the treatment response and the clinical evolution of the disease among carriers. For c.211dupA mutation, two carriers have developed contralateral breast cancer. This observation is similar to those described in the literature where the risk of contralateral recurrence in women with <em>BRCA</em> mutation is approximately 40% at 10 years (<a href="#B61" class="usa-link" aria-describedby="B61">Metcalfe et al., 2004</a>). Besides, two other carriers have developed ovarian cancer 15 and 13 years after their breast cancer. This observation is also in accordance with what has been reported in the literature on the cumulative risk of developing ovarian carcinoma after breast cancer in <em>BRCA1</em> mutation carriers that was estimated to almost 12.7% at 10 years (<em>p</em> = 0.03) (<a href="#B62" class="usa-link" aria-describedby="B62">Metcalfe et al., 2005</a>). It is noteworthy that personal and/or familial ovarian cancer history was present in a high proportion of families (3/5) carrying the c.211dupA mutation.</p>
<p>Based on the risk of contralateral recurrence and the risk of developing ovarian cancer several years after breast cancer, risk-reducing mastectomy (<a href="#B34" class="usa-link" aria-describedby="B34">Hartmann et al., 1999</a>) and salpingo-oophorectomy (<a href="#B69" class="usa-link" aria-describedby="B69">Rebbeck et al., 2002</a>) are recommended for <em>BRCA1</em>-c.211dupA carriers. Moreover, affected cases carrying this mutation could also benefit from personalized therapeutic options. Indeed, the identification of c.211dupA mutation in a metastatic breast cancer patient helped to reorient her therapeutic decision by using carboplatins, platinum-based agents, that are recommended for the treatment of metastatic <em>BRCA</em>-mutated breast cancer with an overall response rate of 80%, including 45% with complete response (<a href="#B13" class="usa-link" aria-describedby="B13">Byrski et al., 2012</a>; <a href="#B92" class="usa-link" aria-describedby="B92">Turner and Tutt, 2012</a>; <a href="#B19" class="usa-link" aria-describedby="B19">Coates et al., 2015</a>).</p>
<p>Therefore, the severe phenotype associated with this mutation (young age of onset, contralateral recurrence, aggressive disease form and ovarian cancer presentation), could be managed if the disease is diagnosed at an early age and if adequate therapeutic and preventive measures are taken.</p>
<p>In the current study, beyond the recurrent founder c.211dupA mutation, a novel private <em>BRCA1</em> mutation, c.2418dupA, was identified in a breast cancer patient from the North-East of Tunisia, using targeted gene sequencing. This mutation has never been reported in previous published studies neither in Tunisia nor in other populations. Furthermore, it is not described in the gnomAD database. However, it is listed and classified in ClinVar as pathogenic. This frameshift mutation is located in <em>BRCA1</em> exon 11 that binds important homologous recombination proteins including RAD50 and RAD51. Recent studies showed that <em>BRCA1</em>-exon 11 constitutes an Ovarian Cancer Clustering Region (OCCR) since mutations located in this region are more associated with ovarian cancer risk than breast cancer (<a href="#B66" class="usa-link" aria-describedby="B66">Orr and Savage, 2015</a>; <a href="#B70" class="usa-link" aria-describedby="B70">Rebbeck et al., 2015</a>).</p>
<p>Using whole exome sequencing, we also identified a rare exonic VUS on <em>RAD50</em> (c.3647C &gt; G, rs1314725075, MAF = 4.061 × 10<sup>–06</sup>) in a breast cancer patient originating also from the North Eastern Tunisian region. Accumulating evidence indicates that <em>RAD50</em> is a breast cancer susceptibility gene associated with genomic instability (<a href="#B35" class="usa-link" aria-describedby="B35">Heikkinen et al., 2003</a>, <a href="#B36" class="usa-link" aria-describedby="B36">2006</a>; <a href="#B38" class="usa-link" aria-describedby="B38">Hsu et al., 2007</a>; <a href="#B22" class="usa-link" aria-describedby="B22">Damiola et al., 2014</a>; <a href="#B44" class="usa-link" aria-describedby="B44">Kleibl and Kristensen, 2016</a>; <a href="#B43" class="usa-link" aria-describedby="B43">Kim et al., 2017</a>; <a href="#B9" class="usa-link" aria-describedby="B9">Bian et al., 2019</a>). Indeed, RAD50 is part of the MRE11/RAD50/NBN (MRN) complex that plays a key role in detecting DNA double-strand breaks, recruiting and activating Ataxia-Telangiectasia Mutated protein (ATM) and in processing the DNA repair pathway (<a href="#B9" class="usa-link" aria-describedby="B9">Bian et al., 2019</a>; <a href="#B85" class="usa-link" aria-describedby="B85">Situ et al., 2019</a>). Mutations in one or more genes forming this complex may lead to hypersensitivity to genotoxic agents and predisposition to malignancy (<a href="#B9" class="usa-link" aria-describedby="B9">Bian et al., 2019</a>).</p>
<p><em>In silico</em> analysis at the sequence and structure levels of hRAD50 protein suggest a deleterious impact of the substitution p.Ala1216Gly. The fact that the amino acid Ala is highly conserved in different distantly related orthologous sequences indicates a high positive selective pressure at that position suggesting, therefore, its functional importance for hRAD50. In addition, A1216 is located in the protein core as part of an α-helix segment that stabilizes the binding sites of ATP. Alanine residue, in particular, is the most stabilizing amino acid for helical secondary structures (<a href="#B82" class="usa-link" aria-describedby="B82">Serrano et al., 1992</a>; <a href="#B52" class="usa-link" aria-describedby="B52">Lopez-Llano et al., 2006</a>). A mutation to glycine, however, would be highly destabilizing for the entire α-helix and consequently for the ATP binding site. Non-capping α-helical Glycine may introduce a significant conformational degree of freedom due to its simple side chain and therefore introduce more flexibility to its local environment. Indeed, Alanine to Glycine mutations were found to have a significant increase in the stabilizing energy of an α helix of 0.4-2 kcal mol<sup>–1</sup> (<a href="#B82" class="usa-link" aria-describedby="B82">Serrano et al., 1992</a>) and in the increase in its local flexibility. Interestingly, the simulation revealed a putative outcome on the interaction of hRAD50 with MRE11 since several residues of the protein-protein interface showed an increase in the local flexibility that need to be investigated further.</p>
<p>Moreover, RAD50 is involved in DNA double-stranded break (DSB) repair by homologous recombination (HR). Recent evidence showed that ovarian cancer patients with a homologous recombination deficiency phenotype (HRD) caused by germline and/or somatic mutations on HR genes exhibit specific clinical behaviors, and improved responses to treatments, such as platinum-based chemotherapy and poly (ADP-ribose) polymerase (PARP) inhibitors (<a href="#B59" class="usa-link" aria-describedby="B59">Mateo et al., 2019</a>). However, based on the latest guidelines released by the American Society of Clinical Oncology (ASCO), clinical decisions for ovarian cancer patients should not be based on VUSs identified on HRD genes (<a href="#B46" class="usa-link" aria-describedby="B46">Konstantinopoulos et al., 2020</a>).</p>
<p>Therefore, re-evaluating the clinical relevance of VUS identified on HR genes such as the <em>RAD50</em> variant characterized in this current study (c.3647C &gt; G) is of keen interest to improve the clinical interpretation of this category of variants and their potential use in precision oncology practice. Indeed, Bope et al., investigated the <em>in silico</em> mutation prediction of variants in African genomes and propose recommendations for re-evaluating the pathogenicity of actionable variants used in research and clinical practice (<a href="#B10" class="usa-link" aria-describedby="B10">Bope et al., 2019</a>). In addition, Dorschener et al., analyzed actionable pathogenic variants in 500 European and 500 African descent using exome data (<a href="#B24" class="usa-link" aria-describedby="B24">Dorschner et al., 2013</a>). The results showed major disparities in Africans with an estimated frequency of around 3.4% for those with European origin and 1.2% for those with African descent. <a href="#B58" class="usa-link" aria-describedby="B58">Manrai et al. (2016)</a> reported a study on patients that were misdiagnosed with hypertrophic cardiomyopathy due to lack of access to non-European data. Indeed, patients from African or unspecified ancestry received positive reports with variants misclassified as pathogenic. Authors concluded that the inclusion of even a small number of African-Americans in control cohorts probably would have prevented this misclassification and misdiagnosis. Therefore, based on this evidence and on the results of our current study, we propose to update the classification of the <em>RAD50</em> c.3647C &gt; G mutation and maybe reclassifying it as “likely pathogenic variant.”</p>
<p>For this same patient, a missense variant associated with PARP inhibitor response, rs28908468, has been identified on <em>RAD51B</em>, which is a paralog of <em>RAD51</em> that has an important role in DNA damage response. Indeed, it was demonstrated that RAD51 is a functional biomarker that enables the identification of PARP inhibitors-sensitive breast cancer cases (<a href="#B14" class="usa-link" aria-describedby="B14">Castroviejo-Bermejo et al., 2018</a>; <a href="#B21" class="usa-link" aria-describedby="B21">Cruz et al., 2018</a>). The <em>RAD51B</em> variant was clearly classified by an expert panel in ClinVar as a variant that affects only the drug response. However, for the <em>RAD50</em> variant, evidence of the pathogenicity was conflicting. Indeed, expert panel evaluation according to the American College of Medical Genetics and Genomics (ACMG) Standards and Guidelines for the interpretation of sequence variants, showed that this variant is of Uncertain Significance (VUS). Thus, we have made an extensive <em>in silico</em> analysis that suggested the need to revise its annotation status.</p>
<p>After investigating known breast cancer genes, we extended our analysis to other genes not yet reported as associated with breast carcinoma. Eleven candidate genes were selected based on several filters, namely: <em>MITF, COL7A1, FOXM1, TSHZ2, AMOTL2, ANKS6, ACACB, LIPE, SNRK, CACNA2D3</em>, and <em>SMG1.</em> Only two variants identified on these genes were listed in ClinVar including one VUS found on <em>ANKS6</em> gene (rs199722684) and a variant of “conflicting interpretations of pathogenicity” identified on <em>MITF</em> gene (rs149617956).</p>
<p>Mutations in <em>ANKS6</em> are known to cause a nephronophthisis-like phenotype (<a href="#B89" class="usa-link" aria-describedby="B89">Taskiran et al., 2014</a>). Based on Cancer Genetic Markers of Susceptibility breast cancer study (CGEMS), 3 SNPs located between <em>ANKS6</em> and <em>GALNT12</em> were identified as significantly associated with breast cancer (<a href="#B37" class="usa-link" aria-describedby="B37">Higginbotham et al., 2012</a>).</p>
<p><em>MITF</em> is associated with development, differentiation, survival and cell cycle regulation. Recent studies showed that the same mutation (rs149617956, E318K) identified on <em>MITF</em>, has been reported as associated with a high risk of melanoma, renal cell carcinoma and pancreatic cancer (<a href="#B32" class="usa-link" aria-describedby="B32">Gromowski et al., 2014</a>; <a href="#B88" class="usa-link" aria-describedby="B88">Sturm et al., 2014</a>). The potential association between E318K and the risk of developing other malignancies such as breast carcinoma has been evaluated by Gromowski et al. Authors concluded that E318K is very rare in breast cancer patients (<a href="#B32" class="usa-link" aria-describedby="B32">Gromowski et al., 2014</a>).</p>
<p>Here we also identified 4 candidate CNVs disrupting 5 genes associated with several carcinomas and involved in interesting biological pathways namely <em>BCL3, COL7A1, RNF5, CEP290</em> and <em>TMTC3.</em> The screening of these CNVs could be considered particularly in breast cancer patients’ non-carriers of pathogenic point mutations.</p></section><section id="S5"><h2 class="pmc_sec_title">Conclusion</h2>
<p>The identification of founder and novel private mutations on <em>BRCA1/2</em> as well as functional variants on genes involved in the homologous recombination pathway has significant impact on genetic screening and clinical management of breast and ovarian cancer patients. Our findings also highlight the importance of the use of NGS technologies in detecting novel mutations involved in breast cancer susceptibility in under-investigated populations. <em>In silico</em> analyses that were performed in this study on <em>RAD50</em>-c.3647C &gt; G variant classified as VUS in ClinVar suggests a re-evaluation of the current classifications of several variants in public databases. Such a reconsideration would improve criteria of pathogenicity assessment by studying African populations, in particular, North Africans that are still poorly investigated.</p></section><section id="S6"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The datasets for this article are not publicly available due to concerns regarding participant/patient anonymity. Requests to access the datasets should be directed to the corresponding author.</p></section><section id="S7"><h2 class="pmc_sec_title">Ethics Statement</h2>
<p>The study was conducted according to the declaration of Helsinki and with the approval of the biomedical ethics committee of Institut Pasteur de Tunis (2017/16/E/Hôpital A-M). Written informed consent was obtained from the participants in this study for the publication of any potentially identifiable images or data included in this article.</p></section><section id="S8"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>NaM did the experiments, analysis, and data interpretation, and drafted the manuscript. YH and MB did analysis and data interpretation, and reviewed the manuscript. MBR contributed in data analysis. SBN, HE, NeM, SL, JA, OJ, HanB, RM, AH, and KR contributed to clinical investigation of patients. HO performed the <em>in silico</em> analyses and reviewed the manuscript. YH and SA contributed to study concept and design. YH, HamB, SB, and SA critically revised the manuscript. YH and SA supervised the study. All authors read and approved the final manuscript.</p></section><section id="conf1"><h2 class="pmc_sec_title">Conflict of Interest</h2>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>We are grateful to all participants and their family members for their participation in the study.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list" id="DL1">
<dt>ACMG</dt>
<dd><p>American College of Medical Genetics and Genomics</p></dd>
<dt>ATM</dt>
<dd><p>ataxia-telangiectasia mutated protein</p></dd>
<dt>CNVs</dt>
<dd><p>copy number variations</p></dd>
<dt>DNA</dt>
<dd><p>deoxyribonucleic acid</p></dd>
<dt>DSB</dt>
<dd><p>double-stranded break</p></dd>
<dt>HER2</dt>
<dd><p>human epidermal growth factor receptor 2</p></dd>
<dt>HR</dt>
<dd><p>homologous recombination</p></dd>
<dt>HRD</dt>
<dd><p>homologous recombination deficiency phenotype</p></dd>
<dt>IDC</dt>
<dd><p>intraductal carcinoma</p></dd>
<dt>InDels</dt>
<dd><p>insertions and deletions</p></dd>
<dt>INS</dt>
<dd><p>Institute of Statistics</p></dd>
<dt>KEGG</dt>
<dd><p>kyoto encyclopedia of genes and genomes</p></dd>
<dt>MAF</dt>
<dd><p>minor allele frequency</p></dd>
<dt>MRN</dt>
<dd><p>MRE11/RAD50/NBN</p></dd>
<dt>NCG</dt>
<dd><p>network of cancer genes</p></dd>
<dt>NGS</dt>
<dd><p>next generation sequencing</p></dd>
<dt>OCCR</dt>
<dd><p>ovarian cancer clustering region</p></dd>
<dt>PARP</dt>
<dd><p>poly (ADP-ribose) polymerase</p></dd>
<dt>PCR</dt>
<dd><p>polymerase chain reaction</p></dd>
<dt>PDB</dt>
<dd><p>protein data bank</p></dd>
<dt>RMSF</dt>
<dd><p>root mean square fluctuation</p></dd>
<dt>SBR</dt>
<dd><p>Scarff-Bloom and Richardson</p></dd>
<dt>SNP</dt>
<dd><p>single nucleotide polymorphism</p></dd>
<dt>SV</dt>
<dd><p>structural variations</p></dd>
<dt>TGS</dt>
<dd><p>target gene sequencing</p></dd>
<dt>TNBC</dt>
<dd><p>triple negative breast cancer</p></dd>
<dt>VarAFT</dt>
<dd><p>variant annotation and filtering tool</p></dd>
<dt>VUS</dt>
<dd><p>variant of unknown significance</p></dd>
<dt>WES</dt>
<dd><p>whole exome sequencing.</p></dd>
</dl></section><section id="fn-group1" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn4"><p><strong>Funding.</strong> This work was supported by the Tunisian Ministry of Higher Education and Scientific Research (LR16IPT05) and the Tunisian Ministry of Public Health (PEC-4-TUN). MB and MBR are recipient of a MOBIDOC fellowship funded by the EU through the EMORI and PASRI programs managed by the ANPR.</p></div></div></section><section id="fn-group2" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="footnote1">
<sup>1</sup><p class="display-inline"><a href="http://www.ins.nat.tn" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.ins.nat.tn</a></p>
</div></div></section><section id="S11"><h2 class="pmc_sec_title">Supplementary Material</h2>
<p>The Supplementary Material for this article can be found online at: <a href="https://www.frontiersin.org/articles/10.3389/fgene.2020.552971/full#supplementary-material" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.frontiersin.org/articles/10.3389/fgene.2020.552971/full#supplementary-material</a></p>
<section class="sm xbox font-sm" id="FS1"><div class="caption p">
<span>Supplementary Figure 1</span><p>Diagram of the Short Tandem Repeats used for the haplotype analysis. This map is based on the information provided by UniSTS, UCSC. The location and order of the loci used in the present study, as well as their physical and genetic positions are shown. These data are extracted from the Marshfield genetic map (Marshfield Center for Medical Genetics).</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7677579/bin/Image_1.TIF" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (568.1KB, TIF) </sup>
</div></div></section><section class="sm xbox font-sm" id="FS2"><div class="caption p">
<span>Supplementary Figure 2</span><p>Assessment of the stereochemical <strong>(A)</strong> and local <strong>(B)</strong> qualities of hRAD50 homology model in comparison with the template structure by establishing the Ramachandran Plot and the Verif3D profile respectively.</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7677579/bin/Image_2.TIF" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (278.9KB, TIF) </sup>
</div></div></section><section class="sm xbox font-sm" id="TS1"><div class="media p"><div class="caption">
<a href="/articles/instance/7677579/bin/Table_1.DOCX" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (15.5KB, DOCX) </sup>
</div></div></section><section class="sm xbox font-sm" id="TS2"><div class="media p"><div class="caption">
<a href="/articles/instance/7677579/bin/Table_2.DOCX" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (25.2KB, DOCX) </sup>
</div></div></section></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ol class="ref-list font-sm">
<li id="B1">
<cite>Akter H., Sultana N., Martuza N., Siddiqua A., Dity N. J., Rahaman M. A., et al.  (2019). Novel mutations in actionable breast cancer genes by targeted sequencing in an ethnically homogenous cohort.
<em>BMC Med. Genet.</em>
20:150.</cite> [<a href="https://doi.org/10.1186/s12881-019-0881-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6721087/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31477031/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Med.%20Genet.&amp;title=Novel%20mutations%20in%20actionable%20breast%20cancer%20genes%20by%20targeted%20sequencing%20in%20an%20ethnically%20homogenous%20cohort.&amp;author=H.%20Akter&amp;author=N.%20Sultana&amp;author=N.%20Martuza&amp;author=A.%20Siddiqua&amp;author=N.%20J.%20Dity&amp;volume=20&amp;issue=150&amp;publication_year=2019&amp;pmid=31477031&amp;doi=10.1186/s12881-019-0881-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<cite>Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. (1990). Basic local alignment search tool.
<em>J. Mol. Biol.</em>
215
403–410.</cite> [<a href="https://doi.org/10.1016/S0022-2836(05)80360-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2231712/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Biol.&amp;title=Basic%20local%20alignment%20search%20tool.&amp;author=S.%20F.%20Altschul&amp;author=W.%20Gish&amp;author=W.%20Miller&amp;author=E.%20W.%20Myers&amp;author=D.%20J.%20Lipman&amp;volume=215&amp;publication_year=1990&amp;pages=403-410&amp;pmid=2231712&amp;doi=10.1016/S0022-2836(05)80360-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<cite>Antoniou A., Pharoah P. D., Narod S., Risch H. A., Eyfjord J. E., Hopper J. L., et al.  (2003). Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies.
<em>Am. J. Hum. Genet.</em>
72
1117– 1130.</cite> [<a href="https://doi.org/10.1086/375033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1180265/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12677558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Hum.%20Genet.&amp;title=Average%20risks%20of%20breast%20and%20ovarian%20cancer%20associated%20with%20BRCA1%20or%20BRCA2%20mutations%20detected%20in%20case%20series%20unselected%20for%20family%20history:%20a%20combined%20analysis%20of%2022%20studies.&amp;author=A.%20Antoniou&amp;author=P.%20D.%20Pharoah&amp;author=S.%20Narod&amp;author=H.%20A.%20Risch&amp;author=J.%20E.%20Eyfjord&amp;volume=72&amp;publication_year=2003&amp;pages=1117-1130&amp;pmid=12677558&amp;doi=10.1086/375033&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<cite>Armes J. E., Egan A. M., Southey M. C., Dite G. S., McCredie M. R., Giles G. G., et al.  (1998). The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study.
<em>Cancer Interdiscip. Int. J. Am. Cancer Soc.</em>
83
2335–2345. </cite> [<a href="https://doi.org/10.1002/(sici)1097-0142(19981201)83:11&amp;#x0003c;2335::aid-cncr13&amp;#x0003e;3.0.co;2-n" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9840533/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Interdiscip.%20Int.%20J.%20Am.%20Cancer%20Soc.&amp;title=The%20histologic%20phenotypes%20of%20breast%20carcinoma%20occurring%20before%20age%2040%20years%20in%20women%20with%20and%20without%20BRCA1%20or%20BRCA2%20germline%20mutations:%20a%20population-based%20study.&amp;author=J.%20E.%20Armes&amp;author=A.%20M.%20Egan&amp;author=M.%20C.%20Southey&amp;author=G.%20S.%20Dite&amp;author=M.%20R.%20McCredie&amp;volume=83&amp;publication_year=1998&amp;pages=2335-2345&amp;pmid=9840533&amp;doi=10.1002/(sici)1097-0142(19981201)83:11&amp;#x0003c;2335::aid-cncr13&amp;#x0003e;3.0.co;2-n&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<cite>Bai J., Zhang X., Kang X., Jin L., Wang P., Wang Z. (2019). Screening of core genes and pathways in breast cancer development via comprehensive analysis of multi gene expression datasets.
<em>Oncol. Lett.</em>
18
5821–5830.</cite> [<a href="https://doi.org/10.3892/ol.2019.10979" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6865771/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31788055/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncol.%20Lett.&amp;title=Screening%20of%20core%20genes%20and%20pathways%20in%20breast%20cancer%20development%20via%20comprehensive%20analysis%20of%20multi%20gene%20expression%20datasets.&amp;author=J.%20Bai&amp;author=X.%20Zhang&amp;author=X.%20Kang&amp;author=L.%20Jin&amp;author=P.%20Wang&amp;volume=18&amp;publication_year=2019&amp;pages=5821-5830&amp;pmid=31788055&amp;doi=10.3892/ol.2019.10979&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<cite>Bektas N., Ten Haaf A., Veeck J., Wild P. J., üscher-Firzlaff J. L., Hartmann A., et al.  (2008). Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer.
<em>BMC Cancer</em>
8:42.</cite> [<a href="https://doi.org/10.1186/1471-2407-8-42" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2265720/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18254960/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=Tight%20correlation%20between%20expression%20of%20the%20Forkhead%20transcription%20factor%20FOXM1%20and%20HER2%20in%20human%20breast%20cancer.&amp;author=N.%20Bektas&amp;author=A.%20Ten%20Haaf&amp;author=J.%20Veeck&amp;author=P.%20J.%20Wild&amp;author=J.%20L.%20%C3%BCscher-Firzlaff&amp;volume=8&amp;issue=42&amp;publication_year=2008&amp;pmid=18254960&amp;doi=10.1186/1471-2407-8-42&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<cite>Berman H., Westbrook J., Feng Z., Gilliland G., Bhat T., Weissig H., et al.  (2000). RCSB protein data bank: structural biology views for basic and applied research.
<em>Nucleic Acids Res.</em>
28
235–242.</cite> [<a href="https://doi.org/10.1093/nar/28.1.235" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC102472/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10592235/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=RCSB%20protein%20data%20bank:%20structural%20biology%20views%20for%20basic%20and%20applied%20research.&amp;author=H.%20Berman&amp;author=J.%20Westbrook&amp;author=Z.%20Feng&amp;author=G.%20Gilliland&amp;author=T.%20Bhat&amp;volume=28&amp;publication_year=2000&amp;pages=235-242&amp;pmid=10592235&amp;doi=10.1093/nar/28.1.235&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<cite>Bewicke-Copley F., Kumar E. A., Palladino G., Korfi K., Wang J. (2019). Applications and analysis of targeted genomic sequencing in cancer studies.
<em>Comput. Struct. Biotechnol. J.</em>
17
1348–1359. 10.1016/j.csbj.2019.10.004
</cite> [<a href="https://doi.org/10.1016/j.csbj.2019.10.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6861594/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31762958/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Comput.%20Struct.%20Biotechnol.%20J.&amp;title=Applications%20and%20analysis%20of%20targeted%20genomic%20sequencing%20in%20cancer%20studies.&amp;author=F.%20Bewicke-Copley&amp;author=E.%20A.%20Kumar&amp;author=G.%20Palladino&amp;author=K.%20Korfi&amp;author=J.%20Wang&amp;volume=17&amp;publication_year=2019&amp;pages=1348-1359&amp;pmid=31762958&amp;doi=10.1016/j.csbj.2019.10.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<cite>Bian L., Meng Y., Zhang M., Li D. (2019). MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment.
<em>Mol. Cancer</em>
18
1–14. 10.1002/9783527678679.dg07931</cite> [<a href="https://doi.org/10.1002/9783527678679.dg07931" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6878665/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31767017/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cancer&amp;title=MRE11-RAD50-NBS1%20complex%20alterations%20and%20DNA%20damage%20response:%20implications%20for%20cancer%20treatment.&amp;author=L.%20Bian&amp;author=Y.%20Meng&amp;author=M.%20Zhang&amp;author=D.%20Li&amp;volume=18&amp;publication_year=2019&amp;pages=1-14&amp;pmid=31767017&amp;doi=10.1002/9783527678679.dg07931&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<cite>Bope C. D., Chimusa E. R., Nembaware V., Mazandu G. K., de Vries J., Wonkam A. (2019). Dissecting in silico mutation prediction of variants in african genomes: challenges and perspectives.
<em>Front. Genet.</em>
10:601.</cite> [<a href="https://doi.org/10.3389/fgene.2019.00601" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6603221/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31293624/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Genet.&amp;title=Dissecting%20in%20silico%20mutation%20prediction%20of%20variants%20in%20african%20genomes:%20challenges%20and%20perspectives.&amp;author=C.%20D.%20Bope&amp;author=E.%20R.%20Chimusa&amp;author=V.%20Nembaware&amp;author=G.%20K.%20Mazandu&amp;author=J.%20de%20Vries&amp;volume=10&amp;issue=601&amp;publication_year=2019&amp;pmid=31293624&amp;doi=10.3389/fgene.2019.00601&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<cite>Bray F., Ferlay J., Soerjomataram I., Siegel R. L., Torre L. A., Jemal A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
<em>CA Cancer J. Clin.</em>
68
394–424. 10.3322/caac.21492
</cite> [<a href="https://doi.org/10.3322/caac.21492" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30207593/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CA%20Cancer%20J.%20Clin.&amp;title=Global%20cancer%20statistics%202018:%20GLOBOCAN%20estimates%20of%20incidence%20and%20mortality%20worldwide%20for%2036%20cancers%20in%20185%20countries.&amp;author=F.%20Bray&amp;author=J.%20Ferlay&amp;author=I.%20Soerjomataram&amp;author=R.%20L.%20Siegel&amp;author=L.%20A.%20Torre&amp;volume=68&amp;publication_year=2018&amp;pages=394-424&amp;pmid=30207593&amp;doi=10.3322/caac.21492&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<cite>Bromberg K. D., Kluger H. M., Delaunay A., Abbas S., DiVito K. A., Krajewski S., et al.  (2007). Increased expression of the E3 ubiquitin ligase RNF5 is associated with decreased survival in breast cancer.
<em>Cancer Res.</em>
67
8172–8179. 10.1158/0008-5472.can-07-0045
</cite> [<a href="https://doi.org/10.1158/0008-5472.can-07-0045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2962863/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17804730/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res.&amp;title=Increased%20expression%20of%20the%20E3%20ubiquitin%20ligase%20RNF5%20is%20associated%20with%20decreased%20survival%20in%20breast%20cancer.&amp;author=K.%20D.%20Bromberg&amp;author=H.%20M.%20Kluger&amp;author=A.%20Delaunay&amp;author=S.%20Abbas&amp;author=K.%20A.%20DiVito&amp;volume=67&amp;publication_year=2007&amp;pages=8172-8179&amp;pmid=17804730&amp;doi=10.1158/0008-5472.can-07-0045&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<cite>Byrski T., Dent R., Blecharz P., Foszczynska-Kloda M., Gronwald J., Huzarski T., et al.  (2012). Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer.
<em>Breast Cancer Res.</em>
14:R110.</cite> [<a href="https://doi.org/10.1186/bcr3231" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3680929/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22817698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.&amp;title=Results%20of%20a%20phase%20II%20open-label,%20non-randomized%20trial%20of%20cisplatin%20chemotherapy%20in%20patients%20with%20BRCA1-positive%20metastatic%20breast%20cancer.&amp;author=T.%20Byrski&amp;author=R.%20Dent&amp;author=P.%20Blecharz&amp;author=M.%20Foszczynska-Kloda&amp;author=J.%20Gronwald&amp;volume=14&amp;issue=R110&amp;publication_year=2012&amp;pmid=22817698&amp;doi=10.1186/bcr3231&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<cite>Castroviejo-Bermejo M., Cruz C., Llop-Guevara A., Gutiérrez-Enríquez S., Ducy M., Ibrahim Y. H., et al.  (2018). A RAD 51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation.
<em>EMBO Mol. Med.</em>
10:e9172.</cite> [<a href="https://doi.org/10.15252/emmm.201809172" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6284440/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30377213/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EMBO%20Mol.%20Med.&amp;title=A%20RAD%2051%20assay%20feasible%20in%20routine%20tumor%20samples%20calls%20PARP%20inhibitor%20response%20beyond%20BRCA%20mutation.&amp;author=M.%20Castroviejo-Bermejo&amp;author=C.%20Cruz&amp;author=A.%20Llop-Guevara&amp;author=S.%20Guti%C3%A9rrez-Enr%C3%ADquez&amp;author=M.%20Ducy&amp;volume=10&amp;issue=e9172&amp;publication_year=2018&amp;pmid=30377213&amp;doi=10.15252/emmm.201809172&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<cite>Chalabi N., Bernard-Gallon D., Bignon Y.-J., agier M., Vidal V., Laplace-Chabaud V., et al.  (2008). Comparative clinical and transcriptomal profiles of breast cancer between French and South Mediterranean patients show minor but significative biological differences.
<em>Cancer Genomics Proteomics</em>
5
253–261.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/19129556/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Genomics%20Proteomics&amp;title=Comparative%20clinical%20and%20transcriptomal%20profiles%20of%20breast%20cancer%20between%20French%20and%20South%20Mediterranean%20patients%20show%20minor%20but%20significative%20biological%20differences.&amp;author=N.%20Chalabi&amp;author=D.%20Bernard-Gallon&amp;author=Y.-J.%20Bignon&amp;author=M.%20agier&amp;author=V.%20Vidal&amp;volume=5&amp;publication_year=2008&amp;pages=253-261&amp;pmid=19129556&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<cite>Chan T. A., Glockner S., Yi J. M., Chen W., Van Neste L., Cope L., et al.  (2008). Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis.
<em>PLoS Med.</em>
5:e114. 10.1371/journal.pmed.0050114
</cite> [<a href="https://doi.org/10.1371/journal.pmed.0050114" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2429944/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18507500/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Med.&amp;title=Convergence%20of%20mutation%20and%20epigenetic%20alterations%20identifies%20common%20genes%20in%20cancer%20that%20predict%20for%20poor%20prognosis.&amp;author=T.%20A.%20Chan&amp;author=S.%20Glockner&amp;author=J.%20M.%20Yi&amp;author=W.%20Chen&amp;author=L.%20Van%20Neste&amp;volume=5&amp;issue=e114&amp;publication_year=2008&amp;pmid=18507500&amp;doi=10.1371/journal.pmed.0050114&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<cite>Chandler M. R., Bilgili E. P., Merner N. D. (2016). A review of whole-exome sequencing efforts toward hereditary breast cancer susceptibility gene discovery.
<em>Hum. Mutat.</em>
37
835–846. 10.1002/humu.23017
</cite> [<a href="https://doi.org/10.1002/humu.23017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27226120/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=A%20review%20of%20whole-exome%20sequencing%20efforts%20toward%20hereditary%20breast%20cancer%20susceptibility%20gene%20discovery.&amp;author=M.%20R.%20Chandler&amp;author=E.%20P.%20Bilgili&amp;author=N.%20D.%20Merner&amp;volume=37&amp;publication_year=2016&amp;pages=835-846&amp;pmid=27226120&amp;doi=10.1002/humu.23017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<cite>Cherbal F., Bakour R., Adane S., Boualga K., Benais-Pont G., Maillet P. (2010). BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families.
<em>Dis. Mark.</em>
28
377–384.</cite> [<a href="https://doi.org/10.3233/DMA-2010-0718" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3833328/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20683152/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dis.%20Mark.&amp;title=BRCA1%20and%20BRCA2%20germline%20mutations%20screening%20in%20Algerian%20breast/ovarian%20cancer%20families.&amp;author=F.%20Cherbal&amp;author=R.%20Bakour&amp;author=S.%20Adane&amp;author=K.%20Boualga&amp;author=G.%20Benais-Pont&amp;volume=28&amp;publication_year=2010&amp;pages=377-384&amp;pmid=20683152&amp;doi=10.3233/DMA-2010-0718&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<cite>Coates A. S., Winer E. P., Goldhirsch A., Gelber R. D., Gnant M., Piccart-Gebhart M., et al.  (2015). Tailoring therapies—improving the management of early breast cancer: St Gallen international expert consensus on the primary therapy of early breast cancer 2015.
<em>Ann. Oncol.</em>
26
1533–1546.</cite> [<a href="https://doi.org/10.1093/annonc/mdv221" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4511219/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25939896/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Oncol.&amp;title=Tailoring%20therapies%E2%80%94improving%20the%20management%20of%20early%20breast%20cancer:%20St%20Gallen%20international%20expert%20consensus%20on%20the%20primary%20therapy%20of%20early%20breast%20cancer%202015.&amp;author=A.%20S.%20Coates&amp;author=E.%20P.%20Winer&amp;author=A.%20Goldhirsch&amp;author=R.%20D.%20Gelber&amp;author=M.%20Gnant&amp;volume=26&amp;publication_year=2015&amp;pages=1533-1546&amp;pmid=25939896&amp;doi=10.1093/annonc/mdv221&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<cite>The Uniport Consortium (2019). UniProt: a worldwide hub of protein knowledge.
<em>Nucleic Acids Res.</em>
47
D506–D515.</cite> [<a href="https://doi.org/10.1093/nar/gky1049" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6323992/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30395287/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=UniProt:%20a%20worldwide%20hub%20of%20protein%20knowledge.&amp;volume=47&amp;publication_year=2019&amp;pages=D506-D515&amp;pmid=30395287&amp;doi=10.1093/nar/gky1049&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<cite>Cruz C., Castroviejo-Bermejo M., Gutiérrez-Enríquez S., Llop-Guevara A., Ibrahim Y., Gris-Oliver A., et al.  (2018). RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer.
<em>Ann. Oncol.</em>
29
1203–1210. 10.1093/annonc/mdy099
</cite> [<a href="https://doi.org/10.1093/annonc/mdy099" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5961353/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29635390/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Oncol.&amp;title=RAD51%20foci%20as%20a%20functional%20biomarker%20of%20homologous%20recombination%20repair%20and%20PARP%20inhibitor%20resistance%20in%20germline%20BRCA-mutated%20breast%20cancer.&amp;author=C.%20Cruz&amp;author=M.%20Castroviejo-Bermejo&amp;author=S.%20Guti%C3%A9rrez-Enr%C3%ADquez&amp;author=A.%20Llop-Guevara&amp;author=Y.%20Ibrahim&amp;volume=29&amp;publication_year=2018&amp;pages=1203-1210&amp;pmid=29635390&amp;doi=10.1093/annonc/mdy099&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<cite>Damiola F., Pertesi M., Oliver J., Calvez-Kelm F. Le, Voegele C., Young E. L., et al.  (2014). Rare key functional domain missense substitutions in MRE11A, RAD50, and NBNcontribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study.
<em>Breast Cancer Res.</em>
16:R58.</cite> [<a href="https://doi.org/10.1186/bcr3669" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4229874/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24894818/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.&amp;title=Rare%20key%20functional%20domain%20missense%20substitutions%20in%20MRE11A,%20RAD50,%20and%20NBNcontribute%20to%20breast%20cancer%20susceptibility:%20results%20from%20a%20Breast%20Cancer%20Family%20Registry%20case-control%20mutation-screening%20study.&amp;author=F.%20Damiola&amp;author=M.%20Pertesi&amp;author=J.%20Oliver&amp;author=F.%20Le%20Calvez-Kelm&amp;author=C.%20Voegele&amp;volume=16&amp;issue=R58&amp;publication_year=2014&amp;pmid=24894818&amp;doi=10.1186/bcr3669&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<cite>Desvignes J.-P., Bartoli M., Delague V., Krahn M., Miltgen M., Béroud C., et al.  (2018). VarAFT: a variant annotation and filtration system for human next generation sequencing data.
<em>Nucleic Acids Res.</em>
46
W545–W553.</cite> [<a href="https://doi.org/10.1093/nar/gky471" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6030844/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29860484/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=VarAFT:%20a%20variant%20annotation%20and%20filtration%20system%20for%20human%20next%20generation%20sequencing%20data.&amp;author=J.-P.%20Desvignes&amp;author=M.%20Bartoli&amp;author=V.%20Delague&amp;author=M.%20Krahn&amp;author=M.%20Miltgen&amp;volume=46&amp;publication_year=2018&amp;pages=W545-W553&amp;pmid=29860484&amp;doi=10.1093/nar/gky471&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<cite>Dorschner M. O., Amendola L. M., Turner E. H., Robertson P. D., Shirts B. H., Gallego C. J., et al.  (2013). Actionable, pathogenic incidental findings in 1,000 participants’ exomes.
<em>Am. J. Hum. Genet.</em>
93
631–640. 10.1016/j.ajhg.2013.08.006
</cite> [<a href="https://doi.org/10.1016/j.ajhg.2013.08.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3791261/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24055113/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Hum.%20Genet.&amp;title=Actionable,%20pathogenic%20incidental%20findings%20in%201,000%20participants%E2%80%99%20exomes.&amp;author=M.%20O.%20Dorschner&amp;author=L.%20M.%20Amendola&amp;author=E.%20H.%20Turner&amp;author=P.%20D.%20Robertson&amp;author=B.%20H.%20Shirts&amp;volume=93&amp;publication_year=2013&amp;pages=631-640&amp;pmid=24055113&amp;doi=10.1016/j.ajhg.2013.08.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<cite>Ebbert M. T., Wadsworth M. E., Staley L. A., Hoyt K. L., Pickett B., Miller J., et al.  (2016). Evaluating the necessity of PCR duplicate removal from next-generation sequencing data and a comparison of approaches.
<em>BMC Bioinformatics</em>
17:239.</cite> [<a href="https://doi.org/10.1186/s12859-016-1097-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4965708/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27454357/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Bioinformatics&amp;title=Evaluating%20the%20necessity%20of%20PCR%20duplicate%20removal%20from%20next-generation%20sequencing%20data%20and%20a%20comparison%20of%20approaches.&amp;author=M.%20T.%20Ebbert&amp;author=M.%20E.%20Wadsworth&amp;author=L.%20A.%20Staley&amp;author=K.%20L.%20Hoyt&amp;author=B.%20Pickett&amp;volume=17&amp;issue=239&amp;publication_year=2016&amp;pmid=27454357&amp;doi=10.1186/s12859-016-1097-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<cite>Fackenthal J. D., Olopade O. I. (2007). Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.
<em>Nat. Rev. Cancer</em>
7:937. 10.1038/nrc2054
</cite> [<a href="https://doi.org/10.1038/nrc2054" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18034184/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Cancer&amp;title=Breast%20cancer%20risk%20associated%20with%20BRCA1%20and%20BRCA2%20in%20diverse%20populations.&amp;author=J.%20D.%20Fackenthal&amp;author=O.%20I.%20Olopade&amp;volume=7&amp;issue=937&amp;publication_year=2007&amp;pmid=18034184&amp;doi=10.1038/nrc2054&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<cite>Ford D., Easton D., Stratton M., Narod S., Goldgar D., Devilee P., et al.  (1998). Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families.
<em>Am. J. Hum. Genet.</em>
62
676–689.</cite> [<a href="https://doi.org/10.1086/301749" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1376944/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9497246/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Hum.%20Genet.&amp;title=Genetic%20heterogeneity%20and%20penetrance%20analysis%20of%20the%20BRCA1%20and%20BRCA2%20genes%20in%20breast%20cancer%20families.&amp;author=D.%20Ford&amp;author=D.%20Easton&amp;author=M.%20Stratton&amp;author=S.%20Narod&amp;author=D.%20Goldgar&amp;volume=62&amp;publication_year=1998&amp;pages=676-689&amp;pmid=9497246&amp;doi=10.1086/301749&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<cite>Fourati A., Louchez M.-M., Fournier J., Gamoudi A., Rahal K., El May M.-V., et al.  (2014). Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
<em>Bull. Cancer</em>
101
E36–E40.</cite> [<a href="https://doi.org/10.1684/bdc.2014.2049" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25418591/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bull.%20Cancer&amp;title=Screening%20for%20common%20mutations%20in%20BRCA1%20and%20BRCA2%20genes:%20interest%20in%20genetic%20testing%20of%20Tunisian%20families%20with%20breast%20and/or%20ovarian%20cancer.&amp;author=A.%20Fourati&amp;author=M.-M.%20Louchez&amp;author=J.%20Fournier&amp;author=A.%20Gamoudi&amp;author=K.%20Rahal&amp;volume=101&amp;publication_year=2014&amp;pages=E36-E40&amp;pmid=25418591&amp;doi=10.1684/bdc.2014.2049&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<cite>Gao Y., Xuan C., Jin M., An Q., Zhuo B., Chen X., et al.  (2019). Ubiquitin ligase RNF5 serves an important role in the development of human glioma.
<em>Oncol. Lett.</em>
18
4659–4666.</cite> [<a href="https://doi.org/10.3892/ol.2019.10801" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6781729/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31611975/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncol.%20Lett.&amp;title=Ubiquitin%20ligase%20RNF5%20serves%20an%20important%20role%20in%20the%20development%20of%20human%20glioma.&amp;author=Y.%20Gao&amp;author=C.%20Xuan&amp;author=M.%20Jin&amp;author=Q.%20An&amp;author=B.%20Zhuo&amp;volume=18&amp;publication_year=2019&amp;pages=4659-4666&amp;pmid=31611975&amp;doi=10.3892/ol.2019.10801&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<cite>Geoffroy V., Herenger Y., Kress A., Stoetzel C., Piton A., Dollfus H., et al.  (2018). AnnotSV: an integrated tool for structural variations annotation.
<em>Bioinformatics</em>
34
3572–3574. 10.1093/bioinformatics/bty304
</cite> [<a href="https://doi.org/10.1093/bioinformatics/bty304" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29669011/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=AnnotSV:%20an%20integrated%20tool%20for%20structural%20variations%20annotation.&amp;author=V.%20Geoffroy&amp;author=Y.%20Herenger&amp;author=A.%20Kress&amp;author=C.%20Stoetzel&amp;author=A.%20Piton&amp;volume=34&amp;publication_year=2018&amp;pages=3572-3574&amp;pmid=29669011&amp;doi=10.1093/bioinformatics/bty304&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31">
<cite>Golmard L., Delnatte C., Laugé A., Moncoutier V., Lefol C., Abidallah K., et al.  (2016). Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations.
<em>Oncogene</em>
35:1324.</cite> [<a href="https://doi.org/10.1038/onc.2015.181" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26028024/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Breast%20and%20ovarian%20cancer%20predisposition%20due%20to%20de%20novo%20BRCA1%20and%20BRCA2%20mutations.&amp;author=L.%20Golmard&amp;author=C.%20Delnatte&amp;author=A.%20Laug%C3%A9&amp;author=V.%20Moncoutier&amp;author=C.%20Lefol&amp;volume=35&amp;issue=1324&amp;publication_year=2016&amp;pmid=26028024&amp;doi=10.1038/onc.2015.181&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32">
<cite>Gromowski T., Masojæ B., Scott R. J., Cybulski C., Górski B., Kluźniak W., et al.  (2014). Prevalence of the E318K and V320I MITF germline mutations in Polish cancer patients and multiorgan cancer risk-a population-based study.
<em>Cancer Genet.</em>
207
128–132. 10.1016/j.cancergen.2014.03.003
</cite> [<a href="https://doi.org/10.1016/j.cancergen.2014.03.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24767713/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Genet.&amp;title=Prevalence%20of%20the%20E318K%20and%20V320I%20MITF%20germline%20mutations%20in%20Polish%20cancer%20patients%20and%20multiorgan%20cancer%20risk-a%20population-based%20study.&amp;author=T.%20Gromowski&amp;author=B.%20Masoj%C3%A6&amp;author=R.%20J.%20Scott&amp;author=C.%20Cybulski&amp;author=B.%20G%C3%B3rski&amp;volume=207&amp;publication_year=2014&amp;pages=128-132&amp;pmid=24767713&amp;doi=10.1016/j.cancergen.2014.03.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33">
<cite>Han M.-R., Long J., Choi J.-Y., Low S.-K., Kweon S.-S., Zheng Y., et al.  (2016). Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.
<em>Hum. Mol. Genet.</em>
25
3361–3371.</cite> [<a href="https://doi.org/10.1093/hmg/ddw164" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5179918/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27354352/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mol.%20Genet.&amp;title=Genome-wide%20association%20study%20in%20East%20Asians%20identifies%20two%20novel%20breast%20cancer%20susceptibility%20loci.&amp;author=M.-R.%20Han&amp;author=J.%20Long&amp;author=J.-Y.%20Choi&amp;author=S.-K.%20Low&amp;author=S.-S.%20Kweon&amp;volume=25&amp;publication_year=2016&amp;pages=3361-3371&amp;pmid=27354352&amp;doi=10.1093/hmg/ddw164&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34">
<cite>Hartmann L. C., Schaid D. J., Woods J. E., Crotty T. P., Myers J. L., Arnold P., et al.  (1999). Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
<em>N. Engl. J. Med.</em>
340
77–84.</cite> [<a href="https://doi.org/10.1056/NEJM199901143400201" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9887158/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=Efficacy%20of%20bilateral%20prophylactic%20mastectomy%20in%20women%20with%20a%20family%20history%20of%20breast%20cancer.&amp;author=L.%20C.%20Hartmann&amp;author=D.%20J.%20Schaid&amp;author=J.%20E.%20Woods&amp;author=T.%20P.%20Crotty&amp;author=J.%20L.%20Myers&amp;volume=340&amp;publication_year=1999&amp;pages=77-84&amp;pmid=9887158&amp;doi=10.1056/NEJM199901143400201&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35">
<cite>Heikkinen K., Karppinen S., Soini Y., Mäkinen M., Winqvist R. (2003). Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility.
<em>J. Med. Genet.</em>
40:e131.</cite> [<a href="https://doi.org/10.1136/jmg.40.12.e131" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1735331/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14684699/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Genet.&amp;title=Mutation%20screening%20of%20Mre11%20complex%20genes:%20indication%20of%20RAD50%20involvement%20in%20breast%20and%20ovarian%20cancer%20susceptibility.&amp;author=K.%20Heikkinen&amp;author=S.%20Karppinen&amp;author=Y.%20Soini&amp;author=M.%20M%C3%A4kinen&amp;author=R.%20Winqvist&amp;volume=40&amp;issue=e131&amp;publication_year=2003&amp;pmid=14684699&amp;doi=10.1136/jmg.40.12.e131&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36">
<cite>Heikkinen K., Rapakko K., Karppinen S.-M., Erkko H., Knuutila S., Lundán T., et al.  (2006). RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability.
<em>Carcinogenesis</em>
27
1593–1599. 10.1093/carcin/bgi360
</cite> [<a href="https://doi.org/10.1093/carcin/bgi360" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3006189/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16474176/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Carcinogenesis&amp;title=RAD50%20and%20NBS1%20are%20breast%20cancer%20susceptibility%20genes%20associated%20with%20genomic%20instability.&amp;author=K.%20Heikkinen&amp;author=K.%20Rapakko&amp;author=S.-M.%20Karppinen&amp;author=H.%20Erkko&amp;author=S.%20Knuutila&amp;volume=27&amp;publication_year=2006&amp;pages=1593-1599&amp;pmid=16474176&amp;doi=10.1093/carcin/bgi360&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37">
<cite>Higginbotham K. S., Breyer J. P., McReynolds K. M., Bradley K. M., Schuyler P. A., Plummer W. D., et al.  (2012). A multistage genetic association study identifies breast cancer risk loci at 10q25 and 16q24.
<em>Cancer Epidemiol. Prevention Biomarkers</em>
21
1565–1573. 10.1158/1055-9965.epi-12-0386
</cite> [<a href="https://doi.org/10.1158/1055-9965.epi-12-0386" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3707501/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22806168/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Epidemiol.%20Prevention%20Biomarkers&amp;title=A%20multistage%20genetic%20association%20study%20identifies%20breast%20cancer%20risk%20loci%20at%2010q25%20and%2016q24.&amp;author=K.%20S.%20Higginbotham&amp;author=J.%20P.%20Breyer&amp;author=K.%20M.%20McReynolds&amp;author=K.%20M.%20Bradley&amp;author=P.%20A.%20Schuyler&amp;volume=21&amp;publication_year=2012&amp;pages=1565-1573&amp;pmid=22806168&amp;doi=10.1158/1055-9965.epi-12-0386&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38">
<cite>Hsu H.-M., Wang H.-C., Chen S.-T., Hsu G.-C., Shen C.-Y., Yu J.-C. (2007). Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex.
<em>Cancer Epidemiol. Prevention Biomarkers</em>
16
2024–2032. 10.1158/1055-9965.epi-07-0116
</cite> [<a href="https://doi.org/10.1158/1055-9965.epi-07-0116" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17932350/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Epidemiol.%20Prevention%20Biomarkers&amp;title=Breast%20cancer%20risk%20is%20associated%20with%20the%20genes%20encoding%20the%20DNA%20double-strand%20break%20repair%20Mre11/Rad50/Nbs1%20complex.&amp;author=H.-M.%20Hsu&amp;author=H.-C.%20Wang&amp;author=S.-T.%20Chen&amp;author=G.-C.%20Hsu&amp;author=C.-Y.%20Shen&amp;volume=16&amp;publication_year=2007&amp;pages=2024-2032&amp;pmid=17932350&amp;doi=10.1158/1055-9965.epi-07-0116&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39">
<cite>Jamroz M., Kolinski A., Kmiecik S. (2014). CABS-flex predictions of protein flexibility compared with NMR ensembles.
<em>Bioinformatics</em>
30
2150–2154. 10.1093/bioinformatics/btu184
</cite> [<a href="https://doi.org/10.1093/bioinformatics/btu184" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4103595/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24735558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=CABS-flex%20predictions%20of%20protein%20flexibility%20compared%20with%20NMR%20ensembles.&amp;author=M.%20Jamroz&amp;author=A.%20Kolinski&amp;author=S.%20Kmiecik&amp;volume=30&amp;publication_year=2014&amp;pages=2150-2154&amp;pmid=24735558&amp;doi=10.1093/bioinformatics/btu184&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40">
<cite>Janavičius R. (2010). Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.
<em>EPMA J.</em>
1
397–412. 10.1007/s13167-010-0037-y
</cite> [<a href="https://doi.org/10.1007/s13167-010-0037-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3405339/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23199084/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EPMA%20J.&amp;title=Founder%20BRCA1/2%20mutations%20in%20the%20Europe:%20implications%20for%20hereditary%20breast-ovarian%20cancer%20prevention%20and%20control.&amp;author=R.%20Janavi%C4%8Dius&amp;volume=1&amp;publication_year=2010&amp;pages=397-412&amp;pmid=23199084&amp;doi=10.1007/s13167-010-0037-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41">
<cite>Jin Y., Cui D., Ren J., Wang K., Zeng T., Gao L. (2017). CACNA2D3 is downregulated in gliomas and functions as a tumor suppressor.
<em>Mol. Carcinogenesis</em>
56
945–959. 10.1002/mc.22548
</cite> [<a href="https://doi.org/10.1002/mc.22548" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27583705/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Carcinogenesis&amp;title=CACNA2D3%20is%20downregulated%20in%20gliomas%20and%20functions%20as%20a%20tumor%20suppressor.&amp;author=Y.%20Jin&amp;author=D.%20Cui&amp;author=J.%20Ren&amp;author=K.%20Wang&amp;author=T.%20Zeng&amp;volume=56&amp;publication_year=2017&amp;pages=945-959&amp;pmid=27583705&amp;doi=10.1002/mc.22548&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42">
<cite>Kanehisa M., Goto S. (2000). KEGG: kyoto encyclopedia of genes and genomes.
<em>Nucleic Acids Res.</em>
28
27–30.</cite> [<a href="https://doi.org/10.1093/nar/28.1.27" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC102409/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10592173/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=KEGG:%20kyoto%20encyclopedia%20of%20genes%20and%20genomes.&amp;author=M.%20Kanehisa&amp;author=S.%20Goto&amp;volume=28&amp;publication_year=2000&amp;pages=27-30&amp;pmid=10592173&amp;doi=10.1093/nar/28.1.27&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43">
<cite>Kim H., Cho D.-Y., Choi D. H., Oh M., Shin I., Park W., et al.  (2017). Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer.
<em>Breast Cancer Res. Treat.</em>
161
95–102. 10.1007/s10549-016-4034-2
</cite> [<a href="https://doi.org/10.1007/s10549-016-4034-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27783279/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat.&amp;title=Frequency%20of%20pathogenic%20germline%20mutation%20in%20CHEK2,%20PALB2,%20MRE11,%20and%20RAD50%20in%20patients%20at%20high%20risk%20for%20hereditary%20breast%20cancer.&amp;author=H.%20Kim&amp;author=D.-Y.%20Cho&amp;author=D.%20H.%20Choi&amp;author=M.%20Oh&amp;author=I.%20Shin&amp;volume=161&amp;publication_year=2017&amp;pages=95-102&amp;pmid=27783279&amp;doi=10.1007/s10549-016-4034-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B44">
<cite>Kleibl Z., Kristensen V. N. (2016). Women at high risk of breast cancer: molecular characteristics, clinical presentation and management.
<em>Breast</em>
28
136–144. 10.1016/j.breast.2016.05.006
</cite> [<a href="https://doi.org/10.1016/j.breast.2016.05.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27318168/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast&amp;title=Women%20at%20high%20risk%20of%20breast%20cancer:%20molecular%20characteristics,%20clinical%20presentation%20and%20management.&amp;author=Z.%20Kleibl&amp;author=V.%20N.%20Kristensen&amp;volume=28&amp;publication_year=2016&amp;pages=136-144&amp;pmid=27318168&amp;doi=10.1016/j.breast.2016.05.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B45">
<cite>Kong X., Li M., Shao K., Yang Y., Wang Q., Cai M. (2020). Progesterone induces cell apoptosis via the CACNA2D3/Ca2+/p38 MAPK pathway in endometrial cancer.
<em>Oncol. Reports</em>
43
121–132.</cite> [<a href="https://doi.org/10.3892/or.2019.7396" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6908942/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31746409/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncol.%20Reports&amp;title=Progesterone%20induces%20cell%20apoptosis%20via%20the%20CACNA2D3/Ca2+/p38%20MAPK%20pathway%20in%20endometrial%20cancer.&amp;author=X.%20Kong&amp;author=M.%20Li&amp;author=K.%20Shao&amp;author=Y.%20Yang&amp;author=Q.%20Wang&amp;volume=43&amp;publication_year=2020&amp;pages=121-132&amp;pmid=31746409&amp;doi=10.3892/or.2019.7396&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>] [<a href="/articles/PMC11267494/" class="text-red">Retracted</a>]</li>
<li id="B46">
<cite>Konstantinopoulos P. A., Norquist B., Lacchetti C., Armstrong D., Grisham R. N., Goodfellow P. J., et al.  (2020). Germline and somatic tumor testing in epithelial ovarian cancer: ASCO guideline.
<em>J. Clin. Oncol.</em>
16
e835–e838.</cite> [<a href="https://doi.org/10.1200/JOP.19.00773" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32074015/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Oncol.&amp;title=Germline%20and%20somatic%20tumor%20testing%20in%20epithelial%20ovarian%20cancer:%20ASCO%20guideline.&amp;author=P.%20A.%20Konstantinopoulos&amp;author=B.%20Norquist&amp;author=C.%20Lacchetti&amp;author=D.%20Armstrong&amp;author=R.%20N.%20Grisham&amp;volume=16&amp;publication_year=2020&amp;pages=e835-e838&amp;pmid=32074015&amp;doi=10.1200/JOP.19.00773&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B47">
<cite>Laarabi F.-Z., Ratbi I., Elalaoui S. C., Mezzouar L., Doubaj Y., Bouguenouch L., et al.  (2017). High frequency of the recurrent c. 1310_1313delAAGA BRCA2 mutation in the North-East of Morocco and implication for hereditary breast–ovarian cancer prevention and control.
<em>BMC Res. Notes</em>
10:188.</cite> [<a href="https://doi.org/10.1186/s13104-017-2511-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5457611/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28577564/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Res.%20Notes&amp;title=High%20frequency%20of%20the%20recurrent%20c.%201310_1313delAAGA%20BRCA2%20mutation%20in%20the%20North-East%20of%20Morocco%20and%20implication%20for%20hereditary%20breast%E2%80%93ovarian%20cancer%20prevention%20and%20control.&amp;author=F.-Z.%20Laarabi&amp;author=I.%20Ratbi&amp;author=S.%20C.%20Elalaoui&amp;author=L.%20Mezzouar&amp;author=Y.%20Doubaj&amp;volume=10&amp;issue=188&amp;publication_year=2017&amp;pmid=28577564&amp;doi=10.1186/s13104-017-2511-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B48">
<cite>Laraqui A., Uhrhammer N., El Rhaffouli H., Sekhsokh Y., Lahlou-Amine I., Bajjou T., et al.  (2015). BRCA genetic screening in Middle Eastern and North African: mutational spectrum and founder BRCA1 mutation (c. 798_799delTT) in North African.
<em>Disease Markers</em>
2015:194293.</cite> [<a href="https://doi.org/10.1155/2015/194293" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4359853/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25814778/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Disease%20Markers&amp;title=BRCA%20genetic%20screening%20in%20Middle%20Eastern%20and%20North%20African:%20mutational%20spectrum%20and%20founder%20BRCA1%20mutation%20(c.%20798_799delTT)%20in%20North%20African.&amp;author=A.%20Laraqui&amp;author=N.%20Uhrhammer&amp;author=H.%20El%20Rhaffouli&amp;author=Y.%20Sekhsokh&amp;author=I.%20Lahlou-Amine&amp;volume=2015&amp;issue=194293&amp;publication_year=2015&amp;pmid=25814778&amp;doi=10.1155/2015/194293&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B49">
<cite>Li H., Durbin R. (2009). Fast and accurate short read alignment with Burrows–Wheeler transform.
<em>Bioinformatics</em>
25
1754–1760. 10.1093/bioinformatics/btp324
</cite> [<a href="https://doi.org/10.1093/bioinformatics/btp324" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2705234/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19451168/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=Fast%20and%20accurate%20short%20read%20alignment%20with%20Burrows%E2%80%93Wheeler%20transform.&amp;author=H.%20Li&amp;author=R.%20Durbin&amp;volume=25&amp;publication_year=2009&amp;pages=1754-1760&amp;pmid=19451168&amp;doi=10.1093/bioinformatics/btp324&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B50">
<cite>Li H., Handsaker B., Wysoker A., Fennell T., Ruan J., Homer N., et al.  (2009). The sequence alignment/map format and SAMtools.
<em>Bioinformatics</em>
25
2078–2079. 10.1093/bioinformatics/btp352
</cite> [<a href="https://doi.org/10.1093/bioinformatics/btp352" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2723002/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19505943/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=The%20sequence%20alignment/map%20format%20and%20SAMtools.&amp;author=H.%20Li&amp;author=B.%20Handsaker&amp;author=A.%20Wysoker&amp;author=T.%20Fennell&amp;author=J.%20Ruan&amp;volume=25&amp;publication_year=2009&amp;pages=2078-2079&amp;pmid=19505943&amp;doi=10.1093/bioinformatics/btp352&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B51">
<cite>Li Y., Zhu C.-L., Nie C.-J., Li J.-C., Zeng T.-T., Zhou J., et al.  (2013). Investigation of tumor suppressing function of CACNA2D3 in esophageal squamous cell carcinoma.
<em>PLoS One</em>
8:e60027. 10.1371/journal.pone.0060027
</cite> [<a href="https://doi.org/10.1371/journal.pone.0060027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3616168/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23560067/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Investigation%20of%20tumor%20suppressing%20function%20of%20CACNA2D3%20in%20esophageal%20squamous%20cell%20carcinoma.&amp;author=Y.%20Li&amp;author=C.-L.%20Zhu&amp;author=C.-J.%20Nie&amp;author=J.-C.%20Li&amp;author=T.-T.%20Zeng&amp;volume=8&amp;issue=e60027&amp;publication_year=2013&amp;pmid=23560067&amp;doi=10.1371/journal.pone.0060027&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B52">
<cite>Lopez-Llano J., Campos L., Sancho J. (2006). α-helix stabilization by alanine relative to glycine: roles of polar and apolar solvent exposures and of backbone entropy.
<em>Proteins Struct. Funct. Bioinformatics</em>
64
769–778. 10.1002/prot.21041
</cite> [<a href="https://doi.org/10.1002/prot.21041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16755589/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proteins%20Struct.%20Funct.%20Bioinformatics&amp;title=%CE%B1-helix%20stabilization%20by%20alanine%20relative%20to%20glycine:%20roles%20of%20polar%20and%20apolar%20solvent%20exposures%20and%20of%20backbone%20entropy.&amp;author=J.%20Lopez-Llano&amp;author=L.%20Campos&amp;author=J.%20Sancho&amp;volume=64&amp;publication_year=2006&amp;pages=769-778&amp;pmid=16755589&amp;doi=10.1002/prot.21041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B53">
<cite>Lovell S. C. I., Davis W., Arendall W. B., III, De Bakker P. I., Word J. M., Prisant M. G., et al.  (2003). Structure validation by Cα geometry: ?, ψ and Cβ deviation.
<em>Proteins Struct. Funct. Bioinformatics</em>
50
437–450. 10.1002/prot.10286
</cite> [<a href="https://doi.org/10.1002/prot.10286" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12557186/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proteins%20Struct.%20Funct.%20Bioinformatics&amp;title=Structure%20validation%20by%20C%CE%B1%20geometry:%20?,%20%CF%88%20and%20C%CE%B2%20deviation.&amp;author=S.%20C.%20I.%20Lovell&amp;author=W.%20Davis&amp;author=W.%20B.%20Arendall&amp;author=P.%20I.%20De%20Bakker&amp;author=J.%20M.%20Word&amp;volume=50&amp;publication_year=2003&amp;pages=437-450&amp;pmid=12557186&amp;doi=10.1002/prot.10286&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B54">
<cite>Lüthy R., Bowie J. U., Eisenberg D. (1992). Assessment of protein models with three-dimensional profiles.
<em>Nature</em>
356
83–85. 10.1038/356083a0
</cite> [<a href="https://doi.org/10.1038/356083a0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1538787/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Assessment%20of%20protein%20models%20with%20three-dimensional%20profiles.&amp;author=R.%20L%C3%BCthy&amp;author=J.%20U.%20Bowie&amp;author=D.%20Eisenberg&amp;volume=356&amp;publication_year=1992&amp;pages=83-85&amp;pmid=1538787&amp;doi=10.1038/356083a0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B55">
<cite>Lv M., Shen Y., Yang J., Li S., Wang B., Chen Z., et al.  (2017). Angiomotin family members: oncogenes or tumor suppressors?
<em>Int. J. Biol. Sci.</em>
13:772. 10.7150/ijbs.19603
</cite> [<a href="https://doi.org/10.7150/ijbs.19603" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5485632/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28656002/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Biol.%20Sci.&amp;title=Angiomotin%20family%20members:%20oncogenes%20or%20tumor%20suppressors?&amp;author=M.%20Lv&amp;author=Y.%20Shen&amp;author=J.%20Yang&amp;author=S.%20Li&amp;author=B.%20Wang&amp;volume=13&amp;issue=772&amp;publication_year=2017&amp;pmid=28656002&amp;doi=10.7150/ijbs.19603&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B56">
<cite>Mahfoudh W., Bouaouina N., Ahmed S. B., Gabbouj S., Shan J., Mathew R., et al.  (2012). Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population.
<em>Mol. Biol. Reports</em>
39
1037–1046. 10.1007/s11033-011-0829-8
</cite> [<a href="https://doi.org/10.1007/s11033-011-0829-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3249560/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21603858/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Biol.%20Reports&amp;title=Hereditary%20breast%20cancer%20in%20Middle%20Eastern%20and%20North%20African%20(MENA)%20populations:%20identification%20of%20novel,%20recurrent%20and%20founder%20BRCA1%20mutations%20in%20the%20Tunisian%20population.&amp;author=W.%20Mahfoudh&amp;author=N.%20Bouaouina&amp;author=S.%20B.%20Ahmed&amp;author=S.%20Gabbouj&amp;author=J.%20Shan&amp;volume=39&amp;publication_year=2012&amp;pages=1037-1046&amp;pmid=21603858&amp;doi=10.1007/s11033-011-0829-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B57">
<cite>Maldonado V., Melendez-Zajgla J. (2011). Role of Bcl-3 in solid tumors.
<em>Mol. Cancer</em>
10:152. 10.1186/1476-4598-10-152
</cite> [<a href="https://doi.org/10.1186/1476-4598-10-152" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3258214/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22195643/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cancer&amp;title=Role%20of%20Bcl-3%20in%20solid%20tumors.&amp;author=V.%20Maldonado&amp;author=J.%20Melendez-Zajgla&amp;volume=10&amp;issue=152&amp;publication_year=2011&amp;pmid=22195643&amp;doi=10.1186/1476-4598-10-152&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B58">
<cite>Manrai A. K., Funke B. H., Rehm H. L., Olesen M. S., Maron B. A., Szolovits P., et al.  (2016). Genetic misdiagnoses and the potential for health disparities.
<em>N. Engl. J. Med.</em>
375
655–665. 10.1056/nejmsa1507092
</cite> [<a href="https://doi.org/10.1056/nejmsa1507092" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5292722/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27532831/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=Genetic%20misdiagnoses%20and%20the%20potential%20for%20health%20disparities.&amp;author=A.%20K.%20Manrai&amp;author=B.%20H.%20Funke&amp;author=H.%20L.%20Rehm&amp;author=M.%20S.%20Olesen&amp;author=B.%20A.%20Maron&amp;volume=375&amp;publication_year=2016&amp;pages=655-665&amp;pmid=27532831&amp;doi=10.1056/nejmsa1507092&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B59">
<cite>Mateo J., Lord C., Serra V., Tutt A., Balmaña J., Castroviejo-Bermejo M., et al.  (2019). A decade of clinical development of PARP inhibitors in perspective.
<em>Ann. Oncol.</em>
30
1437–1447. 10.1093/annonc/mdz192
</cite> [<a href="https://doi.org/10.1093/annonc/mdz192" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6771225/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31218365/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Oncol.&amp;title=A%20decade%20of%20clinical%20development%20of%20PARP%20inhibitors%20in%20perspective.&amp;author=J.%20Mateo&amp;author=C.%20Lord&amp;author=V.%20Serra&amp;author=A.%20Tutt&amp;author=J.%20Balma%C3%B1a&amp;volume=30&amp;publication_year=2019&amp;pages=1437-1447&amp;pmid=31218365&amp;doi=10.1093/annonc/mdz192&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B60">
<cite>McKenna A., Hanna M., Banks E., Sivachenko A., Cibulskis K., Kernytsky A., et al.  (2010). The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.
<em>Genome Res.</em>
20
1297–1303. 10.1101/gr.107524.110
</cite> [<a href="https://doi.org/10.1101/gr.107524.110" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2928508/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20644199/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Res.&amp;title=The%20genome%20analysis%20toolkit:%20a%20MapReduce%20framework%20for%20analyzing%20next-generation%20DNA%20sequencing%20data.&amp;author=A.%20McKenna&amp;author=M.%20Hanna&amp;author=E.%20Banks&amp;author=A.%20Sivachenko&amp;author=K.%20Cibulskis&amp;volume=20&amp;publication_year=2010&amp;pages=1297-1303&amp;pmid=20644199&amp;doi=10.1101/gr.107524.110&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B61">
<cite>Metcalfe K., Lynch H. T., Ghadirian P., Tung N., Olivotto I., Warner E., et al.  (2004). Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
<em>J. Clin. Oncol.</em>
22
2328–2335.</cite> [<a href="https://doi.org/10.1200/JCO.2004.04.033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15197194/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Oncol.&amp;title=Contralateral%20breast%20cancer%20in%20BRCA1%20and%20BRCA2%20mutation%20carriers.&amp;author=K.%20Metcalfe&amp;author=H.%20T.%20Lynch&amp;author=P.%20Ghadirian&amp;author=N.%20Tung&amp;author=I.%20Olivotto&amp;volume=22&amp;publication_year=2004&amp;pages=2328-2335&amp;pmid=15197194&amp;doi=10.1200/JCO.2004.04.033&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B62">
<cite>Metcalfe K. A., Lynch H. T., Ghadirian P., Tung N., I, Olivotto A., Foulkes W. D., et al.  (2005). The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.
<em>Gynecol. Oncol.</em>
96
222–226.</cite> [<a href="https://doi.org/10.1016/j.ygyno.2004.09.039" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15589605/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gynecol.%20Oncol.&amp;title=The%20risk%20of%20ovarian%20cancer%20after%20breast%20cancer%20in%20BRCA1%20and%20BRCA2%20carriers.&amp;author=K.%20A.%20Metcalfe&amp;author=H.%20T.%20Lynch&amp;author=P.%20Ghadirian&amp;author=N.%20Tung&amp;author=A.%20Olivotto&amp;volume=96&amp;publication_year=2005&amp;pages=222-226&amp;pmid=15589605&amp;doi=10.1016/j.ygyno.2004.09.039&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B63">
<cite>Miki Y., Swensen J., Shattuck-Eidens D., Futreal P. A., Harshman K., Tavtigian S., et al.  (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
<em>Science</em>
266
66–71. 10.1126/science.7545954
</cite> [<a href="https://doi.org/10.1126/science.7545954" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7545954/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=A%20strong%20candidate%20for%20the%20breast%20and%20ovarian%20cancer%20susceptibility%20gene%20BRCA1.&amp;author=Y.%20Miki&amp;author=J.%20Swensen&amp;author=D.%20Shattuck-Eidens&amp;author=P.%20A.%20Futreal&amp;author=K.%20Harshman&amp;volume=266&amp;publication_year=1994&amp;pages=66-71&amp;pmid=7545954&amp;doi=10.1126/science.7545954&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B64">
<cite>Msolly A., Kassab A. (2015). BRCA1 and BRCA2 mutations are they related to breast cancer in a sample of tunisian population?
<em>Cancer Ther. Oncol. Int. J.</em>
1
1–5.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Ther.%20Oncol.%20Int.%20J.&amp;title=BRCA1%20and%20BRCA2%20mutations%20are%20they%20related%20to%20breast%20cancer%20in%20a%20sample%20of%20tunisian%20population?&amp;author=A.%20Msolly&amp;author=A.%20Kassab&amp;volume=1&amp;publication_year=2015&amp;pages=1-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B65">
<cite>Nath A., Chan C. (2016). Genetic alterations in fatty acid transport and metabolism genes are associated with metastatic progression and poor prognosis of human cancers.
<em>Sci. Rep.</em>
6:18669.</cite> [<a href="https://doi.org/10.1038/srep18669" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4698658/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26725848/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Rep.&amp;title=Genetic%20alterations%20in%20fatty%20acid%20transport%20and%20metabolism%20genes%20are%20associated%20with%20metastatic%20progression%20and%20poor%20prognosis%20of%20human%20cancers.&amp;author=A.%20Nath&amp;author=C.%20Chan&amp;volume=6&amp;issue=18669&amp;publication_year=2016&amp;pmid=26725848&amp;doi=10.1038/srep18669&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B66">
<cite>Orr K. S., Savage K. I. (2015). <em>Advances in DNA Repair</em>, Intech.
217–253.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Advances%20in%20DNA%20Repair&amp;author=K.%20S.%20Orr&amp;author=K.%20I.%20Savage&amp;publication_year=2015&amp;pages=217-253&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B67">
<cite>Plagnol V., Curtis J., Epstein M., Mok K. Y., Stebbings E., Grigoriadou S., et al.  (2012). A robust model for read count data in exome sequencing experiments and implications for copy number variant calling.
<em>Bioinformatics</em>
28
2747–2754. 10.1093/bioinformatics/bts526
</cite> [<a href="https://doi.org/10.1093/bioinformatics/bts526" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3476336/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22942019/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=A%20robust%20model%20for%20read%20count%20data%20in%20exome%20sequencing%20experiments%20and%20implications%20for%20copy%20number%20variant%20calling.&amp;author=V.%20Plagnol&amp;author=J.%20Curtis&amp;author=M.%20Epstein&amp;author=K.%20Y.%20Mok&amp;author=E.%20Stebbings&amp;volume=28&amp;publication_year=2012&amp;pages=2747-2754&amp;pmid=22942019&amp;doi=10.1093/bioinformatics/bts526&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B68">
<cite>Posey J. E. (2019). Genome sequencing and implications for rare disorders.
<em>Orphanet J. Rare Dis.</em>
14:153.</cite> [<a href="https://doi.org/10.1186/s13023-019-1127-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6591893/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31234920/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Orphanet%20J.%20Rare%20Dis.&amp;title=Genome%20sequencing%20and%20implications%20for%20rare%20disorders.&amp;author=J.%20E.%20Posey&amp;volume=14&amp;issue=153&amp;publication_year=2019&amp;pmid=31234920&amp;doi=10.1186/s13023-019-1127-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B69">
<cite>Rebbeck T. R., Lynch H. T., Neuhausen S. L., Narod S. A., Van’t Veer L., Garber J. E., et al.  (2002). Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
<em>N. Engl. J. Med.</em>
346
1616–1622.</cite> [<a href="https://doi.org/10.1056/NEJMoa012158" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12023993/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=Prophylactic%20oophorectomy%20in%20carriers%20of%20BRCA1%20or%20BRCA2%20mutations.&amp;author=T.%20R.%20Rebbeck&amp;author=H.%20T.%20Lynch&amp;author=S.%20L.%20Neuhausen&amp;author=S.%20A.%20Narod&amp;author=L.%20Van%E2%80%99t%20Veer&amp;volume=346&amp;publication_year=2002&amp;pages=1616-1622&amp;pmid=12023993&amp;doi=10.1056/NEJMoa012158&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B70">
<cite>Rebbeck T. R., Mitra N., Wan F., Sinilnikova O. M., Healey S., McGuffog L., et al.  (2015). Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
<em>JAMA</em>
313
1347–1361.</cite> [<a href="https://doi.org/10.1001/jama.2014.5985" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4537700/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25849179/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Association%20of%20type%20and%20location%20of%20BRCA1%20and%20BRCA2%20mutations%20with%20risk%20of%20breast%20and%20ovarian%20cancer.&amp;author=T.%20R.%20Rebbeck&amp;author=N.%20Mitra&amp;author=F.%20Wan&amp;author=O.%20M.%20Sinilnikova&amp;author=S.%20Healey&amp;volume=313&amp;publication_year=2015&amp;pages=1347-1361&amp;pmid=25849179&amp;doi=10.1001/jama.2014.5985&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B71">
<cite>Reeve J. P., Rannala B. (2002). DMLE+: Bayesian linkage disequilibrium gene mapping.
<em>Bioinformatics</em>
18
894–895. 10.1093/bioinformatics/18.6.894
</cite> [<a href="https://doi.org/10.1093/bioinformatics/18.6.894" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12075030/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=DMLE+:%20Bayesian%20linkage%20disequilibrium%20gene%20mapping.&amp;author=J.%20P.%20Reeve&amp;author=B.%20Rannala&amp;volume=18&amp;publication_year=2002&amp;pages=894-895&amp;pmid=12075030&amp;doi=10.1093/bioinformatics/18.6.894&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B72">
<cite>Repana D., Nulsen J., Dressler L., Bortolomeazzi M., Venkata S. K., Tourna A., et al.  (2019). The network of cancer genes (NCG): a comprehensive catalogue of known and candidate cancer genes from cancer sequencing screens.
<em>Genome Biol.</em>
20:1.</cite> [<a href="https://doi.org/10.1186/s13059-018-1612-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6317252/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30606230/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Biol.&amp;title=The%20network%20of%20cancer%20genes%20(NCG):%20a%20comprehensive%20catalogue%20of%20known%20and%20candidate%20cancer%20genes%20from%20cancer%20sequencing%20screens.&amp;author=D.%20Repana&amp;author=J.%20Nulsen&amp;author=L.%20Dressler&amp;author=M.%20Bortolomeazzi&amp;author=S.%20K.%20Venkata&amp;volume=20&amp;issue=1&amp;publication_year=2019&amp;pmid=30606230&amp;doi=10.1186/s13059-018-1612-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B73">
<cite>Riahi A., Kharrat M., Ghourabi M., Khomsi F., Gamoudi A., Lariani I., et al.  (2015). Mutation spectrum and prevalence of BRCA 1 and BRCA 2 genes in patients with familial and early-onset breast/ovarian cancer from Tunisia.
<em>Clin. Genet.</em>
87
155–160. 10.1111/cge.12337
</cite> [<a href="https://doi.org/10.1111/cge.12337" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24372583/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Genet.&amp;title=Mutation%20spectrum%20and%20prevalence%20of%20BRCA%201%20and%20BRCA%202%20genes%20in%20patients%20with%20familial%20and%20early-onset%20breast/ovarian%20cancer%20from%20Tunisia.&amp;author=A.%20Riahi&amp;author=M.%20Kharrat&amp;author=M.%20Ghourabi&amp;author=F.%20Khomsi&amp;author=A.%20Gamoudi&amp;volume=87&amp;publication_year=2015&amp;pages=155-160&amp;pmid=24372583&amp;doi=10.1111/cge.12337&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B74">
<cite>Rice P., Longden I., Bleasby A. (2000). EMBOSS: the European molecular biology open software suite.
<em>Trends Genet.</em>
16
276–277. 10.1016/s0168-9525(00)02024-2</cite> [<a href="https://doi.org/10.1016/s0168-9525(00)02024-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10827456/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20Genet.&amp;title=EMBOSS:%20the%20European%20molecular%20biology%20open%20software%20suite.&amp;author=P.%20Rice&amp;author=I.%20Longden&amp;author=A.%20Bleasby&amp;volume=16&amp;publication_year=2000&amp;pages=276-277&amp;pmid=10827456&amp;doi=10.1016/s0168-9525(00)02024-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B75">
<cite>Riku M., Inaguma S., Ito H., Tsunoda T., Ikeda H., Kasai K. (2016). Down-regulation of the zinc-finger homeobox protein TSHZ2 releases GLI1 from the nuclear repressor complex to restore its transcriptional activity during mammary tumorigenesis.
<em>Oncotarget</em>
7:5690. 10.18632/oncotarget.6788
</cite> [<a href="https://doi.org/10.18632/oncotarget.6788" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4868714/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26744317/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Down-regulation%20of%20the%20zinc-finger%20homeobox%20protein%20TSHZ2%20releases%20GLI1%20from%20the%20nuclear%20repressor%20complex%20to%20restore%20its%20transcriptional%20activity%20during%20mammary%20tumorigenesis.&amp;author=M.%20Riku&amp;author=S.%20Inaguma&amp;author=H.%20Ito&amp;author=T.%20Tsunoda&amp;author=H.%20Ikeda&amp;volume=7&amp;issue=5690&amp;publication_year=2016&amp;pmid=26744317&amp;doi=10.18632/oncotarget.6788&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B76">
<cite>Rines A. K., Burke M. A., Fernandez R. P., Volpert O. V., Ardehali H. (2012). Snf1-related kinase inhibits colon cancer cell proliferation through calcyclin-binding protein-dependent reduction of β-catenin.
<em>FASEB J.</em>
26
4685–4695. 10.1096/fj.12-212282
</cite> [<a href="https://doi.org/10.1096/fj.12-212282" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3475258/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22874833/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FASEB%20J.&amp;title=Snf1-related%20kinase%20inhibits%20colon%20cancer%20cell%20proliferation%20through%20calcyclin-binding%20protein-dependent%20reduction%20of%20%CE%B2-catenin.&amp;author=A.%20K.%20Rines&amp;author=M.%20A.%20Burke&amp;author=R.%20P.%20Fernandez&amp;author=O.%20V.%20Volpert&amp;author=H.%20Ardehali&amp;volume=26&amp;publication_year=2012&amp;pages=4685-4695&amp;pmid=22874833&amp;doi=10.1096/fj.12-212282&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B77">
<cite>Rodrigues C. H., Pires D. E., Ascher D. B. (2018). DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability.
<em>Nucleic Acids Res.</em>
46
W350–W355.</cite> [<a href="https://doi.org/10.1093/nar/gky300" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6031064/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29718330/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=DynaMut:%20predicting%20the%20impact%20of%20mutations%20on%20protein%20conformation,%20flexibility%20and%20stability.&amp;author=C.%20H.%20Rodrigues&amp;author=D.%20E.%20Pires&amp;author=D.%20B.%20Ascher&amp;volume=46&amp;publication_year=2018&amp;pages=W350-W355&amp;pmid=29718330&amp;doi=10.1093/nar/gky300&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B78">
<cite>Romdhane L., Kefi R., Azaiez H., Halim N. B., Dellagi K., Abdelhak S. (2012). Founder mutations in Tunisia: implications for diagnosis in North Africa and Middle East.
<em>Orphanet J. Rare Dis.</em>
7:52. 10.1186/1750-1172-7-52
</cite> [<a href="https://doi.org/10.1186/1750-1172-7-52" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3495028/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22908982/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Orphanet%20J.%20Rare%20Dis.&amp;title=Founder%20mutations%20in%20Tunisia:%20implications%20for%20diagnosis%20in%20North%20Africa%20and%20Middle%20East.&amp;author=L.%20Romdhane&amp;author=R.%20Kefi&amp;author=H.%20Azaiez&amp;author=N.%20B.%20Halim&amp;author=K.%20Dellagi&amp;volume=7&amp;issue=52&amp;publication_year=2012&amp;pmid=22908982&amp;doi=10.1186/1750-1172-7-52&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B79">
<cite>Šali A., Blundell T. L. (1993). Comparative protein modelling by satisfaction of spatial restraints.
<em>J. Mol. Biol.</em>
234
779–815. 10.1006/jmbi.1993.1626
</cite> [<a href="https://doi.org/10.1006/jmbi.1993.1626" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8254673/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Biol.&amp;title=Comparative%20protein%20modelling%20by%20satisfaction%20of%20spatial%20restraints.&amp;author=A.%20%C5%A0ali&amp;author=T.%20L.%20Blundell&amp;volume=234&amp;publication_year=1993&amp;pages=779-815&amp;pmid=8254673&amp;doi=10.1006/jmbi.1993.1626&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B80">
<cite>Seifert F. U., Lammens K., Stoehr G., Kessler B., Hopfner K. P. (2016). Structural mechanism of ATP-dependent DNA binding and DNA end bridging by eukaryotic Rad50.
<em>EMBO J.</em>
35
759–772. 10.15252/embj.201592934
</cite> [<a href="https://doi.org/10.15252/embj.201592934" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4818761/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26896444/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EMBO%20J.&amp;title=Structural%20mechanism%20of%20ATP-dependent%20DNA%20binding%20and%20DNA%20end%20bridging%20by%20eukaryotic%20Rad50.&amp;author=F.%20U.%20Seifert&amp;author=K.%20Lammens&amp;author=G.%20Stoehr&amp;author=B.%20Kessler&amp;author=K.%20P.%20Hopfner&amp;volume=35&amp;publication_year=2016&amp;pages=759-772&amp;pmid=26896444&amp;doi=10.15252/embj.201592934&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B81">
<cite>Seklani M. (1974). <em>La Population de la Tunisie. Presses de la Société Tunisienne des Arts Graphiques</em>.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=La%20Population%20de%20la%20Tunisie.%20Presses%20de%20la%20Soci%C3%A9t%C3%A9%20Tunisienne%20des%20Arts%20Graphiques&amp;author=M.%20Seklani&amp;publication_year=1974&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B82">
<cite>Serrano L., Neira J.-L., Sancho J., Fersht A. R. (1992). Effect of alanine versus glycine in α-helices on protein stability.
<em>Nature</em>
356
453–455. 10.1038/356453a0
</cite> [<a href="https://doi.org/10.1038/356453a0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1557131/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Effect%20of%20alanine%20versus%20glycine%20in%20%CE%B1-helices%20on%20protein%20stability.&amp;author=L.%20Serrano&amp;author=J.-L.%20Neira&amp;author=J.%20Sancho&amp;author=A.%20R.%20Fersht&amp;volume=356&amp;publication_year=1992&amp;pages=453-455&amp;pmid=1557131&amp;doi=10.1038/356453a0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B83">
<cite>Shahi R. B., De Brakeleer S., Caljon B., Pauwels I., Bonduelle M., Joris S., et al.  (2019). Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.
<em>BMC Cancer</em>
19:313.</cite> [<a href="https://doi.org/10.1186/s12885-019-5494-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6449945/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30947698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=Identification%20of%20candidate%20cancer%20predisposing%20variants%20by%20performing%20whole-exome%20sequencing%20on%20index%20patients%20from%20BRCA1%20and%20BRCA2-negative%20breast%20cancer%20families.&amp;author=R.%20B.%20Shahi&amp;author=S.%20De%20Brakeleer&amp;author=B.%20Caljon&amp;author=I.%20Pauwels&amp;author=M.%20Bonduelle&amp;volume=19&amp;issue=313&amp;publication_year=2019&amp;pmid=30947698&amp;doi=10.1186/s12885-019-5494-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B84">
<cite>Shen M. Y., Sali A. (2006). Statistical potential for assessment and prediction of protein structures.
<em>Protein Sci.</em>
15
2507–2524. 10.1110/ps.062416606
</cite> [<a href="https://doi.org/10.1110/ps.062416606" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2242414/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17075131/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Protein%20Sci.&amp;title=Statistical%20potential%20for%20assessment%20and%20prediction%20of%20protein%20structures.&amp;author=M.%20Y.%20Shen&amp;author=A.%20Sali&amp;volume=15&amp;publication_year=2006&amp;pages=2507-2524&amp;pmid=17075131&amp;doi=10.1110/ps.062416606&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B85">
<cite>Situ Y., Chung L., Lee C. S., Ho V. (2019). MRN (MRE11-RAD50-NBS1) complex in human cancer and prognostic implications in colorectal cancer.
<em>Int. J. Mol. Sci.</em>
20:816. 10.3390/ijms20040816
</cite> [<a href="https://doi.org/10.3390/ijms20040816" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6413120/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30769804/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=MRN%20(MRE11-RAD50-NBS1)%20complex%20in%20human%20cancer%20and%20prognostic%20implications%20in%20colorectal%20cancer.&amp;author=Y.%20Situ&amp;author=L.%20Chung&amp;author=C.%20S.%20Lee&amp;author=V.%20Ho&amp;volume=20&amp;issue=816&amp;publication_year=2019&amp;pmid=30769804&amp;doi=10.3390/ijms20040816&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B86">
<cite>Slenter D. N., Kutmon M., Hanspers K., Riutta A., Windsor J., Nunes N., et al.  (2017). WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research.
<em>Nucleic Acids Res.</em>
46
D661–D667.</cite> [<a href="https://doi.org/10.1093/nar/gkx1064" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5753270/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29136241/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=WikiPathways:%20a%20multifaceted%20pathway%20database%20bridging%20metabolomics%20to%20other%20omics%20research.&amp;author=D.%20N.%20Slenter&amp;author=M.%20Kutmon&amp;author=K.%20Hanspers&amp;author=A.%20Riutta&amp;author=J.%20Windsor&amp;volume=46&amp;publication_year=2017&amp;pages=D661-D667&amp;pmid=29136241&amp;doi=10.1093/nar/gkx1064&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B87">
<cite>Stephens M., Smith N. J., Donnelly P. (2001). A new statistical method for haplotype reconstruction from population data.
<em>Am. J. Hum. Genet.</em>
68
978–989. 10.1086/319501
</cite> [<a href="https://doi.org/10.1086/319501" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1275651/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11254454/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Hum.%20Genet.&amp;title=A%20new%20statistical%20method%20for%20haplotype%20reconstruction%20from%20population%20data.&amp;author=M.%20Stephens&amp;author=N.%20J.%20Smith&amp;author=P.%20Donnelly&amp;volume=68&amp;publication_year=2001&amp;pages=978-989&amp;pmid=11254454&amp;doi=10.1086/319501&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B88">
<cite>Sturm R. A., Fox C., McClenahan P., Jagirdar K., Ibarrola-Villava M., Banan P., et al.  (2014). Phenotypic characterization of nevus and tumor patterns in MITF E318K mutation carrier melanoma patients.
<em>J. Invest. Dermatol.</em>
134
141–149. 10.1038/jid.2013.272
</cite> [<a href="https://doi.org/10.1038/jid.2013.272" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23774529/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Invest.%20Dermatol.&amp;title=Phenotypic%20characterization%20of%20nevus%20and%20tumor%20patterns%20in%20MITF%20E318K%20mutation%20carrier%20melanoma%20patients.&amp;author=R.%20A.%20Sturm&amp;author=C.%20Fox&amp;author=P.%20McClenahan&amp;author=K.%20Jagirdar&amp;author=M.%20Ibarrola-Villava&amp;volume=134&amp;publication_year=2014&amp;pages=141-149&amp;pmid=23774529&amp;doi=10.1038/jid.2013.272&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B89">
<cite>Taskiran E. Z., Korkmaz E., Gucer S., Kosukcu C., Kaymaz F., Koyunlar C., et al.  (2014). Mutations in ANKS6 cause a nephronophthisis-like phenotype with ESRD.
<em>J. Am. Soc. Nephrol.</em>
25
1653–1661. 10.1681/asn.2013060646
</cite> [<a href="https://doi.org/10.1681/asn.2013060646" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4116054/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24610927/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Soc.%20Nephrol.&amp;title=Mutations%20in%20ANKS6%20cause%20a%20nephronophthisis-like%20phenotype%20with%20ESRD.&amp;author=E.%20Z.%20Taskiran&amp;author=E.%20Korkmaz&amp;author=S.%20Gucer&amp;author=C.%20Kosukcu&amp;author=F.%20Kaymaz&amp;volume=25&amp;publication_year=2014&amp;pages=1653-1661&amp;pmid=24610927&amp;doi=10.1681/asn.2013060646&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B90">
<cite>Troudi W., Uhrhammer N., Romdhane K. B., Sibille C., Amor M. B., Khil E., et al.  (2008). Complete mutation screening and haplotype characterization of BRCA1 gene in Tunisian patients with familial breast cancer.
<em>Cancer Biomarkers</em>
4
11–18. 10.3233/cbm-2008-4102
</cite> [<a href="https://doi.org/10.3233/cbm-2008-4102" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18334730/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Biomarkers&amp;title=Complete%20mutation%20screening%20and%20haplotype%20characterization%20of%20BRCA1%20gene%20in%20Tunisian%20patients%20with%20familial%20breast%20cancer.&amp;author=W.%20Troudi&amp;author=N.%20Uhrhammer&amp;author=K.%20B.%20Romdhane&amp;author=C.%20Sibille&amp;author=M.%20B.%20Amor&amp;volume=4&amp;publication_year=2008&amp;pages=11-18&amp;pmid=18334730&amp;doi=10.3233/cbm-2008-4102&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B91">
<cite>Troudi W., Uhrhammer N., Sibille C., Dahan C., Mahfoudh W., Souissi C. B., et al.  (2007). Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia.
<em>J. Hum. Genet.</em>
52:915.</cite> [<a href="https://doi.org/10.1007/s10038-007-0195-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17922257/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Hum.%20Genet.&amp;title=Contribution%20of%20the%20BRCA1%20and%20BRCA2%20mutations%20to%20breast%20cancer%20in%20Tunisia.&amp;author=W.%20Troudi&amp;author=N.%20Uhrhammer&amp;author=C.%20Sibille&amp;author=C.%20Dahan&amp;author=W.%20Mahfoudh&amp;volume=52&amp;issue=915&amp;publication_year=2007&amp;pmid=17922257&amp;doi=10.1007/s10038-007-0195-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B92">
<cite>Turner N. C., Tutt A. N. (2012). Platinum chemotherapy for BRCA1-related breast cancer: do we need more evidence?
<em>BioMed Central</em>
14:115.</cite> [<a href="https://doi.org/10.1186/bcr3332" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4053124/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23146216/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BioMed%20Central&amp;title=Platinum%20chemotherapy%20for%20BRCA1-related%20breast%20cancer:%20do%20we%20need%20more%20evidence?&amp;author=N.%20C.%20Turner&amp;author=A.%20N.%20Tutt&amp;volume=14&amp;issue=115&amp;publication_year=2012&amp;pmid=23146216&amp;doi=10.1186/bcr3332&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B93">
<cite>Uhrhammer N., Abdelouahab A., Lafarge L., Feillel V., Dib A. B., Bignon Y.-J. (2008). BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases.
<em>Int. J. Med. Sci.</em>
5:197. 10.7150/ijms.5.197
</cite> [<a href="https://doi.org/10.7150/ijms.5.197" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2452980/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18645608/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Med.%20Sci.&amp;title=BRCA1%20mutations%20in%20Algerian%20breast%20cancer%20patients:%20high%20frequency%20in%20young,%20sporadic%20cases.&amp;author=N.%20Uhrhammer&amp;author=A.%20Abdelouahab&amp;author=L.%20Lafarge&amp;author=V.%20Feillel&amp;author=A.%20B.%20Dib&amp;volume=5&amp;issue=197&amp;publication_year=2008&amp;pmid=18645608&amp;doi=10.7150/ijms.5.197&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B94">
<cite>Wong A. M. G., Kong K. L., Chen L., Liu M., Wong A. M. G., Zhu C., et al.  (2013). Characterization of CACNA2D3 as a putative tumor suppressor gene in the development and progression of nasopharyngeal carcinoma.
<em>Int. J. Cancer</em>
133
2284–2295. 10.1002/ijc.28252
</cite> [<a href="https://doi.org/10.1002/ijc.28252" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23649311/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Cancer&amp;title=Characterization%20of%20CACNA2D3%20as%20a%20putative%20tumor%20suppressor%20gene%20in%20the%20development%20and%20progression%20of%20nasopharyngeal%20carcinoma.&amp;author=A.%20M.%20G.%20Wong&amp;author=K.%20L.%20Kong&amp;author=L.%20Chen&amp;author=M.%20Liu&amp;author=A.%20M.%20G.%20Wong&amp;volume=133&amp;publication_year=2013&amp;pages=2284-2295&amp;pmid=23649311&amp;doi=10.1002/ijc.28252&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B95">
<cite>Wong C., Chen F., Alirezaie N., Wang Y., Cuggia A., Borgida A., et al.  (2019). A region-based gene association study combined with a leave-one-out sensitivity analysis identifies SMG1 as a pancreatic cancer susceptibility gene.
<em>PLoS Genet.</em>
15:e1008344. 10.1371/journal.pgen.1008344
</cite> [<a href="https://doi.org/10.1371/journal.pgen.1008344" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6742418/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31469826/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Genet.&amp;title=A%20region-based%20gene%20association%20study%20combined%20with%20a%20leave-one-out%20sensitivity%20analysis%20identifies%20SMG1%20as%20a%20pancreatic%20cancer%20susceptibility%20gene.&amp;author=C.%20Wong&amp;author=F.%20Chen&amp;author=N.%20Alirezaie&amp;author=Y.%20Wang&amp;author=A.%20Cuggia&amp;volume=15&amp;issue=e1008344&amp;publication_year=2019&amp;pmid=31469826&amp;doi=10.1371/journal.pgen.1008344&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B96">
<cite>Wood L. D., Parsons D. W., Jones S., Lin J., Sjöblom T., Leary R. J., et al.  (2007). The genomic landscapes of human breast and colorectal cancers.
<em>Science</em>
318
1108–1113.</cite> [<a href="https://doi.org/10.1126/science.1145720" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17932254/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=The%20genomic%20landscapes%20of%20human%20breast%20and%20colorectal%20cancers.&amp;author=L.%20D.%20Wood&amp;author=D.%20W.%20Parsons&amp;author=S.%20Jones&amp;author=J.%20Lin&amp;author=T.%20Sj%C3%B6blom&amp;volume=318&amp;publication_year=2007&amp;pages=1108-1113&amp;pmid=17932254&amp;doi=10.1126/science.1145720&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B97">
<cite>Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., et al.  (1995). Identification of the breast cancer susceptibility gene BRCA2.
<em>Nature</em>
378:789.</cite> [<a href="https://doi.org/10.1038/378789a0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8524414/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Identification%20of%20the%20breast%20cancer%20susceptibility%20gene%20BRCA2.&amp;author=R.%20Wooster&amp;author=G.%20Bignell&amp;author=J.%20Lancaster&amp;author=S.%20Swift&amp;author=S.%20Seal&amp;volume=378&amp;issue=789&amp;publication_year=1995&amp;pmid=8524414&amp;doi=10.1038/378789a0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B98">
<cite>Zhu Y., Wu J., Zhang C., Sun S., Zhang J., Liu W., et al.  (2016). BRCA mutations and survival in breast cancer: an updated systematic review and meta-analysis.
<em>Oncotarget</em>
7:70113. 10.18632/oncotarget.12158
</cite> [<a href="https://doi.org/10.18632/oncotarget.12158" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5342539/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27659521/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=BRCA%20mutations%20and%20survival%20in%20breast%20cancer:%20an%20updated%20systematic%20review%20and%20meta-analysis.&amp;author=Y.%20Zhu&amp;author=J.%20Wu&amp;author=C.%20Zhang&amp;author=S.%20Sun&amp;author=J.%20Zhang&amp;volume=7&amp;issue=70113&amp;publication_year=2016&amp;pmid=27659521&amp;doi=10.18632/oncotarget.12158&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ol></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>Supplementary Figure 1</span><p>Diagram of the Short Tandem Repeats used for the haplotype analysis. This map is based on the information provided by UniSTS, UCSC. The location and order of the loci used in the present study, as well as their physical and genetic positions are shown. These data are extracted from the Marshfield genetic map (Marshfield Center for Medical Genetics).</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7677579/bin/Image_1.TIF" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (568.1KB, TIF) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p">
<span>Supplementary Figure 2</span><p>Assessment of the stereochemical <strong>(A)</strong> and local <strong>(B)</strong> qualities of hRAD50 homology model in comparison with the template structure by establishing the Ramachandran Plot and the Verif3D profile respectively.</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7677579/bin/Image_2.TIF" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (278.9KB, TIF) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/7677579/bin/Table_1.DOCX" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (15.5KB, DOCX) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/7677579/bin/Table_2.DOCX" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (25.2KB, DOCX) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets for this article are not publicly available due to concerns regarding participant/patient anonymity. Requests to access the datasets should be directed to the corresponding author.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Frontiers in Genetics are provided here courtesy of <strong>Frontiers Media SA</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3389/fgene.2020.552971"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/fgene-11-552971.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.9 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/7677579/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/7677579/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC7677579%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC7677579/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC7677579/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC7677579/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/33240314/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC7677579/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/33240314/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC7677579/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/7677579/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="YcEDJAcGTGLyhn0JhUKDX47EsISc9sOtAm4QvsFeaofSstvKxT8duc0kzAhpcdjY">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
